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ABSTRACT OF THE THESIS
MOLECULAR CHARACTERIZATION OF GcC8 ALPHA, THE FUNCTIONAL
HOMOLOGUE OF HUMAN C8 ALPHA IN THE SHARK, GINGLYMOSTOMA
CIRRATUM
by
Lydia Tatiana Aybar
Florida International University, 2010

Miami, Florida
Professor Charles H. Bigger, Major Professor

The focus of this study is to elucidate the components of the nurse shark
(Ginglymostoma cirratum) membrane attack complex (MAC), specifically complement
component C8a (GcC8u). Nurse shark C8a gene was cloned, sequenced, and analyzed
and Western blot analysis performed to identify components of shark MAC. GcC8a
consists of 2341 nucleotides that translate into a 589 amino acid sequence that shares
41.1% and 47.4 % identity with human and xenopus C8a, respectively. GcC8a conserves
the MAC modular architecture and cysteine-rich backbone characteristic of complement
proteins, including the cysteine residue that forms the C8a-y bond as well as the indel
that is unique to C8a. Conservation of MAC protein structure is evident from cross-

reactivity of antihuman-MAC antibodies with shark serum proteins in Western blots
which confirmed the presence of C8 and C9-like proteins in shark serum, however, did
not resolve the question of whether C6 and/or C7 like proteins are present in shark.
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CHAPTER I.
INTRODUCTION
The focus of this study is to elucidate the components of the shark membrane
attack complex (MAC), specifically its C8a ortholog. To further our understanding of
the evolution of the complement system, it is essential that components of the cascade be

defined, specifically the characterization of the genes that encode the key proteins like
those involved in membrane attack. As a first step in this endeavor, the nurse shark C8a
gene was cloned, sequenced, and analyzed and Western blot analysis was performed to

assess individual constituents of shark MAC, the end product of the terminal pathway of
complement.

The complement system is a group of heat labile serum proteins that are generally
synthesized by the liver and that circulate as inactive precursors (with the exception of
factor D). Complement activation occurs via three distinct activation pathways: the

classical (CP), the alternative (AP), or the lectin (LP) (Muller-Eberhard, 1988; Volanakis,
1998; Lambris et al., 1999). All three activation pathways converge into a single
terminal lytic pathway leading to the formation of MAC (Podack, 1988). MAC
glycoproteins, C5b-C9, assemble sequentially, penetrate target cell membranes, and
cause cell death (Podack, 1988). Complement genes, including those that encode the
MAC proteins, are believed to have been generated by gene duplication events (Ohno,

1970; Nonaka et al, 1994). This view point is supported by the similar modular
architecture of MAC proteins (C6 through C9) and that they are more similar to one
another than they are to genes of proteins composing the activation pathways of the
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complement system (CP, AP, LP), although all complement proteins do share some
common structural motifs.

The mammalian MAC family of proteins is structurally

composed of combinations of several modules or domains such as the thrombospondin
type I (T1), low-density lipoprotein receptor class A (LA), epidermal growth factor
precursor (EG) modules, and a large MAC-perforin (MACPF) domain (Figure 1)
(Gonzalez et al., 1996). These modules are conserved in mammals (Gonzalez et al.,

1996); amphibians (unpublished - genbank sequences); and teleosts (Papanastasiou and
Zakardis, 2005; 2006a and b). This study provides evidence of a MAC gene in an
elasmobranch, the nurse shark Ginglymostoma cirratum, the most basal organism to have

a gene that is characteristic of the MAC family. This study further shows that the key
MAC structural modules, T1, LA, EG, and MACPF, are present in the shark and suggests

functional similarity of shark MAC to that of its mammalian homologue and a degree of
similar antigenic structure since antibodies to human C8 and C9 cross react with shark C8

and C9 in Western blots.

The lytic activity of the nurse shark (Ginglymostoma cirratum) complement
system involves functional analogues of mammalian C8 and C9 (Jensen et al., 1973;

1981). This report is the first to describe the human C8a subunit ortholog in the shark,
GcC8a.

The GcC8a gene consists of 2341 nucleotides that translate into a 589 amino

acid sequence that shares 41.1% and 47.4 % identity with human and xenopus C8a,
respectively. GcC8a conserves the MAC modular architecture and cysteine-rich peptide
backbone characteristic of complement proteins, including the cysteine residue that forms
the C8a-y bond. Southern blot analysis shows that GcC8a exists as a single-copy gene
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expressed in most tissues with the liver being the main site of synthesis. To further prove
that GcC8a is a C8a ortholog, phylogenetic analysis places it in a clade with other C8a
orthologs and as a sister taxa to Xenopus. The hydrophobicity profile of GcC8a is

consistent with the human C8a hydrophobicity pattern with the presence of hydrophobic
residues essential for membrane insertion. The conservation of structure and possibly

function of MAC proteins is supported by Western blot analysis of shark serum which
shows proteins cross-reactive with human anti-MAC antibodies.

This study begins to elucidate shark MAC, specifically its C8a ortholog, to
further our understanding of the evolution of an ancient and important part of the innate

immune system, the complement system.
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Figure 1. Modular structure of mammalian MAC protein family. Modules are labeled as
follows: thrombospondin type I (TI), low-density lipoprotein receptor class A (LA),
MAC-perforin (MACPF) domain, epidermal growth factor precursor (EG), Complement
control protein (CP), Factor I module (FI). Numbers correspond to protein amino acid
residues. Asterisks correspond to potential N-linked glycosylation sites.
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CHAPTER II.
BACKGROUND
The nurse shark, Ginglymostoma cirratum, is a primitive member of the
vertebrate phyla and, by virtue of its phylogenetic position, serves as an excellent animal
model to study ancestral complement genes and proteins, including those of the MAC.
The shark immune system has elements of innate and adaptive immunity and, for the
purposes of this study, a functional complement system complete with a terminal lytic

pathway (Jensen et al., 1973; 1981; Smith, 1998; Smith and Jensen, 1986). Hemolytic
activity of shark serum has been known for decades (Legler and Evans, 1967), and transmembrane pore structures formed on target membranes have been shown to be
structurally similar to those formed by mammalian MAC (Humphrey and Dourmashkin,

1969; Jensen et al., 1981; Ramm et al, 1982). The shark is the earliest vertebrate for
which complement-associated lytic activity has been definitively established and the
functional homologues of shark C8 and C9 partially purified (Jensen et al., 1973; 1981);
however, the complete molecular composition of shark MAC has not been determined,
nor have genes and/or proteins of individual MAC components C6 through C9 been
cloned or characterized. The mammalian complement system also includes a complex

system of regulatory and control proteins some of which are cell surface-associated
proteins (Liszewski et al., 1996).
Mammalian Complement

The complement system is an enzymatic cascade that was named after its ability
to 'complement' antibodies in clearing pathogens from an organism (Atkinson and Frank,

1974a and b). Complement has been well-characterized in mammals and consists of three
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activation pathways that converge at C3 and ends in the formation of MAC via the
terminal, lytic pathway, MAC (Muller-Eberhard, 1988; G6tze and Mller-Eberhard,

1971).
Although the complement system is an integral part of innate immunity, it

interacts with a component of the adaptive system and thus serves as a bridge between
the two systems (Atkinson and Frank, 1974a and b). When complement is activated, a
chain of sequential events ensue that leads to the generation of biologically active

peptides and assembly of MAC on target membranes (i.e., bacterial cells and transformed
self cells). This supramolecular complex penetrates target membranes to form doughnut-

shaped holes and causes lysis of cells and organisms that leads to cell death (Podack,
1988).
Non-mammalian Complement
Complement has been present in a variety of diverse forms in taxa throughout

evolution.

Genetic evidence for a C3-homologue has been reported in coral, Swiftia

exertia, (Dishaw et al., 2005) and halocynthins (Gross et al., 1999; Marino et al. 2002).
One important element of complement conspicuously missing from organisms more basal
than elasmobranchs is a terminal lytic pathway. Functional studies in the lamprey (a
cyclostome that precedes the shark in evolution) have shown that the opsonic factors of
the complement system are present, i.e., C3-Like proteins, but no evidence of assembly
of a functional membrane attack complex has been detected (Nonaka et al., 1984),
indicating that initiation pathways may be present, but terminated without assembly and
execution of membrane attack. In the nurse shark, terminal lysis (Jensen et al.

1973;1981; Smith and Jensen, 1986) is present along with functional evidence of the
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classical and alternative pathways (Smith, 1998), designating the shark as the most basal
organism to have a complete lytic complement system, similar to that found in mammals
and other higher vertebrates.

Mammalian MAC
MAC formation is initiated by C5b generated by the activation cleavage of C5
and followed by the sequential assembly of complement proteins C6, C7, C8 (a,

p3,

and y

subunits) and several molecules of C9. The insertion of C5b-C9(n) complex into the
target membrane disrupts membrane integrity by forming transmembrane pore-like
structures that make cells leaky (Muller-Eberhard, 1988) (Figure 2). The assembly of
MAC and its subsequent insertion into the lipid bilayer of target membranes depend on
the ability of the terminal components (C6 through C9) to undergo conformational

changes involving hydrophilic-amphiphilic molecular transition to expose hydrophobic
domains to the complementary binding domain of the succeeding MAC protein (Kolb et
al, 1972; Kolb and Muller-Eberhart, 1972; Sodetz, 1989; Hadders etal, 2007). A
conformational change in C5b allows the non-covalent attachment of C6. Binding of C7
to the C5b6 complex exposes concealed hydrophobic sites within the C7 molecule, thus

permitting insertion of the C5b-C7 complex into the target membrane. Anchored in this
way, C5b-7 serves as a receptor for C8. The C5b-C8 complex then undergoes a
conformational change that exposes a site on C8P that begins the polymerization of
multiple molecules of C9 (1-18 in humans) to form a barrel-like tubular structure through

the target membrane (Kolb and Muller-Eberhard, 1974; Podack et al, 1978). These
channels disrupt target membranes, leading to cell lysis and death from leakage (Podack
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and Tschopp, 1984). The two terminal components, C8 and C9, are crucial for target cell
lysis.
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Figure 2. Sequential assembly of the membrane attack complex via the terminal lytic
pathway of mammalian complement.

The lytic proteins of cytotoxic lymphocytes, natural killer (NK) cells, and MAC
proteins share several common structural motifs, specifically the MACPF domain. The
damage caused by MAC is similar to the trans-membrane channels formed by perforin
molecules of NK cells on target membranes (Young et al., 1986). Perform is a protein

found in cytolytic T and NK cells that polymerizes to form the same type of doughnutshaped holes as MAC. In the presence of calcium, perforin polymerizes into

transmembrane tubules and is capable of lysing, non-specifically, a variety of target cells
(Podack et al., 1989). It is generally believed that MAC proteins, C6 through C9 and
perforin, arose through a series of gene duplications of an ancestral perforin-like gene
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(Mondragon-Palomino et al., 1999). Thus the MAC complement proteins are considered
members of a gene family that includes the perforins.
MAC proteins have high homology to each other, and their interactions are highly
specific as is their interaction with target cell membranes (Brannen and Sodetz, 2007).
The disulfide bond between C8a and y subunits and the non-covalent binding site of C8P

to C8a are located in the MACPF domain (Plumb et al., 1999). CD59 (protectin)
prevents MAC formation by sequestering part of the MACPF domain of C8a to keep C9

from binding and polymerizing. CD59, a 20 kDa glycophosphatidylinositol-linked glycol
protein that acts by binding to C8 and C9 to inhibit the formation of the lytic pore, is

widely expressed, as it is crucial in preventing destruction of "self' cells by preventing
MAC deposition (Kimberley et al., 2007). C9 requires the C8a LA module as well as the
MACPF domain to complete MAC formation (Scibeck et al., 2002).
Two components of MAC differ in genetic structure and belong to non-MAC

protein families: C5b and C8y. C5 is cleaved by C5 convertase into C5a and C5b.
C5a is an anaphlytoxin involved in the inflammatory response and causes smooth muscle
contraction and vasodilation (Sodetz and Plumb, 2001). C5b is a cleavage product of
activated C5 that is structurally similar and genetically related to the thioester-containing
u 2 Macroglobulin (a2M) protein family, which consists of C3, C4, C5, and a2M (Sodetz
and Plumb, 2001), and differs from other MAC proteins quite distinctly in that it can noncovalently attach to target membranes to initiate the assembly of MAC, while C8y is a
lipocalin and modulates inflammatory responses (Haefliger et al., 1991). Parker and
Sodetz (2002) have shown that MAC can be assembled without C8y (Brickner and
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Sodetz, 1984) . In addition, Trojer et al. (1999) have detected it in the human fetal and
adult kidney independent of its C8y counterpart, signifying that these subunits may have
roles distinct from complement action. Furthermore, the C8y gene (C8G) is located on a
different human chromosome (9q) than C8a and C8P, distantly from C8A and C8B
genes (human chromosome 1p32), and because it may not have undergone the gene

duplication events it may have evolved separately from other MAC constituents
(Platterborze et al, 1996: Rittner et al., 1986).

Duplication of MAC Genes
Biological systems contain many examples of genes that have arisen through the

mechanism of gene duplication, which complementologists generally accept as playing
an important role in the evolution of the complement system (Nonaka, 2001). Gene
duplication in the complement system can be a unique strategy for the immune system to
increase the range of recognition of foreign molecules (Sunyer et al., 1998; Nakao et al,
2006). The complement system consists of several examples of related proteins that have

arisen by gene duplication, as shown by gene sequence similarity and repetitive modular
domain analysis (Figure 1).

Several sets of complement components have been

discovered in the mammalian complement system that are believed to have arisen from a
common ancestor: Cir/Cls, MASP1/MASP2, factor B/C2, C3/C4/C5, and C8a/C8P.
These homologous proteins and genes indicate that gene duplication events are common
in this system and have given rise to multiple components with similar structures,
functions, and domains which are believed to strengthen the functional repertoire of the
complement system (Nonaka and Smith, 2000). The overall component structure of
complement of teleost and cartilaginous fish is similar to that of mammals; this suggests
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that tetraploidization may have caused the increase in the number of components and
emerged after divergence of the cartilaginous fish (Nonaka and Smith, 2000). In-depth

sequence and domain analysis indicate that the MAC proteins C6, C7, C8a, C8,

and C9

underwent frequent gene duplication and exon-shuffling that resulted in sequential
addition and deletion of the different modular domains (Volankis and Frank, 1998).

Module Similarity
Modules are protein scaffolds that have been conserved through biological

evolution (Campbell, 2003). One purpose of modules is to provide a binding surface to
facilitate interactions among a diverse array of macromolecules, like those of the MAC

family, to form dynamic complexes (Campbell, 2003). The MAC proteins C6, C7, C8a,
C8p, and C9 consist of several cysteine-rich domains or modules such as T1, LA,
MACPF, and EG modules (Figure 1) that are commonly found in immune proteins, but
that are more structurally and genetically related to each other than to other complement

proteins (Sodetz and Plumb, 2001). Some of these modules were first described in
systems that were non-complement and non-immune system-related proteins (Morley and
Walport, 2000). One essential module present in all MAC proteins (with the exception of
C5b and C8y) is the MACPF domain (Figure 1). The presence of common modules is a
primary element that suggests that these proteins arose from gene duplication.

Non-Mammalian MAC
Information on the composition of MAC for non-mammalian species is
incomplete, particularly for lower vertebrates, although genes homologous to mammalian

MAC genes and/or proteins have been described for birds (Mikrou and Zarkadis, 2010),
frogs (McLin et al., 2008), and teleosts (Nakao et al. 1998; Papanastasiou and Zakardis,
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2005). Little is known of the biological activities associated with these genes and how
they compare with those of higher vertebrates (Scapigliati et al., 2001). Molecular tools
have revealed complement genes in organisms as ancient as corals (Dishaw et al., 2005)

and ascidians (Nonaka et al., 1999), demonstrating that complement-like activity is an
ancient immune mechanism. However, a fully functional enzymatic cascade has been
described only for the gnathostomes and other vertebrate species, and a functional
terminal pathway has not been described in organisms more basal than the shark.
Although genes and some components of the classical and alternative activation

pathways have been found in agnathans, echinoderms (Smith et al., 1999; Smith et al,
2001) and even cnidarians that evolved prior to the protostome/deuterostome split
(Dishaw et al., 2005), no associated target cell lysis has been observed in the afore named

organisms and no MAC proteins have been isolated or genes cloned, with the exception
of a C6-like gene that has been cloned from amphioxus, a chephalochordate (Suzuki,

2002). Whether the encoded protein functions as a component of a MAC in amphioxus
remains to be determined. These genes suggest potential modular structures but are

significantly different in composition (Suzuki, 2002).
Individual components analogous to those of the lytic pathway in mammals (i.e.,
C6 through C9) have been described only for few non-mammalian species. C8P has been
cloned and characterized in the Japanese flounder, Paralicththysolivaceous (Kalgiri et
al., 1999). All three C8 gene subunits have been isolated from carp, Cyprinus carpio
(Uemura et al., 1996). C8 a, 3, and y genes have been cloned and sequenced in the
rainbow trout, Oncorhynchus mykiss (Papanastasiou and Zarkadis, 2005; Kazantzi et al.,
2003) and in the frog (Xenopus tropicalis)(genbank sequences, unpublished). Studies of

11

these genes show that the modular architecture (T1, LA, EG, MACPF) shown in Figure 1
has been conserved in amphibian and teleost MAC counterparts.

Shark MAC
Studies of the complement system in cartilaginous fish have shown functional

parallels to mammals that share analogous components (Smith, 1998). Hemolytic
activity of shark serum has been recognized for decades, and trans-membrane pore
structures formed on target membranes have been shown to be structurally similar to

those formed by mammalian MAC (Jensen et al., 1973:1981). The shark complement
system has been shown to be structurally and functionally similar to that of humans and

other vertebrates (Smith and Jensen, 1986; Shin et al., 2007; Graham et al., 2009; Shin et
al., 2009). In the shark, C8 and C9 functional analogues can lyse target cells with human
EAC1-C7 or EAC1-C8 cells, respectively (Jensen et al., 1973;1981). Although the shark
is the earliest vertebrate for which complement-associated lytic activity has been
definitively established, the molecular composition of shark MAC has not been
determined nor have genes and/or proteins of individual MAC components C6 through
C9 been cloned or characterized. Earlier functional data indicated the presence of C8 and
C9 homologues (referred to as C8n and C9n or tl and t2) in the shark and the proteins
were functionally purified from serum.

Mammalian C8
Mammalian C8 is a trimeric oligomer composed of non-identical subunits, a, (3,

and y chains, each encoded by a separate gene (C8A, C8B, and C8G) (Steckel et al.,
1980; Ng et al, 1987). As a native composite serum protein, human C8 has a molecular

weight of 151 kDa, composed of an a chain (64 kDa), a P chain (64 kDa), and a y chain
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(22 kDa) (Kolb and Muller-Eberhard, 1976). Structurally, the y subunit belongs to the
lipocalin family and is unrelated to the MAC complement protein family. C8A and C8B
are located on chromosome lp32, and C8G is located on 9q (Rittner et al., 1986).

While C5b-7 complex is assembled on the membrane, the binding of C8 to the
complex embeds the complex further into the membrane, causing the target cells to

slightly leak. C8 is the first MAC protein to completely insert in the lipid bilayer of the
"target" membrane, initiating the anchoring of MAC, which is facilitated through the
C8a subunit (Steckel et al., 1980). C8j in turn is non-covalently bound to the disulfide-

linked C8a and C8y subunits. The C8a subunit has a crucial role in completing the
assembly of MAC since it rapidly binds and initiates the self-polymerization of C9
molecules which insert into the lipid bilayer and cause osmotic lysis (Musingarimi et al,
2002). C8a is a subunit that also contains a host of several essential binding sites for the

formation and control of MAC function (Plumb et al 1999). It is a unique member of
MAC since it is the only MAC protein that hosts a characteristic indel (insertion/deletion

sequence) (Plumb and Sodetz, 2000).

Shark C8
Previous studies on shark have shown the presence of a 185 kDa C8 functional
analogue (Jensen et al.1981); however, details of its primary, secondary, and subunit
structure were unknown. The goal of the present study was to define shark C8 structure
by characterizing the gene(s) of one or more C8 subunits. This report documents,
characterizes, and presents the first nucleotide sequence of a MAC protein in the shark in
an evolutionary context using phylogenetic analysis.
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CHAPTER III.
MATERIALS AND METHODS
Harvesting of Nurse Shark Tissues
A 2- Kg young female nurse shark was captured from the waters near the Keys

Marine Laboratory (KML), Long Key, Florida, and transported in seawater to Florida
International University (FIU) for sacrifice and subsequent tissue harvesting. The animal
was anesthetized with 1 part per million (ppm) of 3-aminobenzoic acid ethyl ester

(methane sulfonate) and allowed to bleed out from the caudal vein. After careful
dissection, the tissues were flash-frozen in liquid nitrogen and stored at -80°C until used

for nucleic acid extraction.
Shark Blood Collection and Processing
Captive adult nurse sharks were kept in an open seawater channel at the KML.
All animals were tagged with an identification number to ensure that animals were not

bled more frequently than once every eight weeks. Sharks were anesthetized by handcapturing by net and placing into a concrete bath filled with seawater containing 1 ppm of
3-aminobenzoic acid ethyl ester (methane sulfonate). Anesthetized sharks were removed

from the tank and placed in a supine position. Peripheral blood was aseptically drawn
from the caudal vein with an 18-gauge sterile needle directly into a 30- or 60-ml syringe.
After bleeding, the anesthetized sharks were returned to the water channel and walked to
allow the water to flow through the gills until normal respiratory function was restored.

For shark DNA isolation from blood cells, shark blood was added to queen's lysis
buffer in a 1:40 ratio and mixed by inversion for 10 m, then placed on ice in a dark
cooler.

To collect shark serum, shark blood was immediately placed in sterile 50-mL
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polypropylene tubes, wrapped in foil, and placed on ice for transport back to the lab. The
tubes were transferred to a 4°C refrigerator for 24 h to clot. Before centrifugation, a
sterile wooden applicator stick was used to release the clot from the perimeter of the tube.

The tubes were centrifuged in a Beckman GPR centrifuge at 4°C, 12,000 x g for 10-15 m.
Separated serum was decanted in one fluid movement from the clot into a 50-mL sterile
Pyrex glass tube without disturbing the clot. Since some erythrocytes and leukocytes do
transfer with the serum, the serum was centrifuged again to remove all erythrocytes and

cellular debris at 15,000 x g at 4°C for 15-20 m. Clear serum was decanted in to a 50-mL
sterile glass Pyrex screw cap tube and stored in a circulating refrigerated water bath
(NESLAB) at 00 C until further use for functional studies or Western blot analysis. For
long term storage, serum was stored frozen at -20°C.

Total RNA Extraction from Shark Tissues
Shark tissues (liver, kidney, brain, intestine, ovary, muscle, heart, pancreas,

spleen, erythrocytes, and leukocytes) were removed from the -80°C freezer and from
each tissue a small sample of approximately 50-100 mg (or 1x 107 cells) was removed and

placed into a 1.5 ml eppendorf tube and homogenized by Kontes Pellet Pestle® motor in
1-ml of TRIzol Reagent (Invitrogen Life Technologies) and left to incubate at room
temperature for 5 m. Next, 200 ul of chloroform was added to each tissue sample
homogenate, shaken vigorously, and incubated at room temperature for 2 m. Samples
were centrifuged at 12,000 x g for 15 m at 4°C. After centrifugation, the RNAcontaining aqueous phase was transferred to a sterile 1.5 ml eppendorf tube. RNA was
precipitated by adding 0.5 ml isopropanol and the tube gently inverted and incubated for
10 m at room temperature. This mixture was centrifuged at 12,000 x g for 15 m at 4°C.
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The supernatant was decanted, and the RNA pellet washed with 1 ml of 75% ethanol,
vortexed, and spun at 7,500 x g for 5 m at 4°C. The ethanol was decanted and the RNA
pellet left to air-dry for 10 m. The extracted RNA was dissolved in DEPC treated water
and stored at -80°C.
First-strand cDNA Synthesis, Degenerate RT-PCR, and Product Cloning

Total RNA was extracted from homogenized nurse shark liver using the TRIzol
Reagent (Invitrogen Life Technologies) according to manufacturer instructions (detailed

above). Using Superscript II reverse transcriptase and Oligo(dT)12-18 primer
(Invitrogen Life Technologies), first-stranded cDNA was synthesized using 4 ug of total
RNA as the template. Degenerate primer NSC9-DGF1 (Table 1) was based on a highly
conserved region (CNGDQDC, human amino acids 115-121) of human C6, C7, C8a,
C8p, and C9-deduced amino acid sequences and employed in RT-PCR. NSC9-DGF1
was paired with abridged universal amplification primer (AUAP) (Clontech) for RTPCR.

Table 1: Primers used for sequence analysis, synthesizing PCR- Digoxigenin (DIG)
probes, and RT-PCR analysis of the GcC8a gene.
Sequence 5'- 3'

Primer Name

_____________________________sequences

an

____________

NSC9-DGF1
C8ASAZNFP3
C8ASAZNRP1
NSC8A-L2
NSC8A-L3
C8A33F
C8AFP10
C8A-seqRP1
C8A-SQRP 1
C8A-SQRP2
C8A-SQRP3

GYAAYGGNGAYAAYGAYTGYG
CAAACAGCGAACACGAAGC
GAAATCAACAAAGAACACAGAG
GCCGAAAAATCCGAAGTGTA
GACTGGAGGGAACTGCGATA
AGGCATTGGCACAGTCAG
TGTCTGCCTGGTTATGAAGG
CTGGACTTTCTTGCTTCAC
TGGTTTTCGGTAGCATTTCTC
TTACCGAGCCACCCACA
GGCACGCTTTCCCTTCAT
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115-121
1712-1731
1916-1937
143-162
610-629
1121-1138
1606-1625
218-236
667-687
1212-1228
1619-1636

C8a-ESFP2
C8a-ESRP1
beta-actin F
beta-actin R
M13F

ATTACACTGCATGAAGAATGA
CTGGTAATGATGGACCTGG
CTGCCATGTATGTTGCCATC
ATCCACATCTGCTGGAAGGT
TGTAAAACGACGGCCAGT

11-31
2075-2093
389-408
1051-1070

M13R
GTTTTCCCAGTCACGAC
a Indicates the amino acid position in human C8a chain

Conditions for Amplification of GcC8a DNA sequence
The thermocycler was set for 94°C for 1 m and 35 cycles of 94°C for 30 s, 56°C
for 30 s, and 71 C for 3 m and for a final extension for 6 m. DNA fragments of 2.1 and
2.9 Kb were detected by electrophoresis and further amplified by nested PCR
(SMARTRACE cDNA amplification kit, Invitrogen Life Technologies) under
thermocycler settings of 94°C for 30 s, 62°C for 30 s, 72°C for 3 m, and 30 s for 25
cycles. The PCR products were run on a 1% agarose gel and further purified using the

QIAquick gel extraction kit (Qiagen) according to manufacturer's instructions. The
extracted products were cloned into a TOPO-TA 1 OF' vector (Invitrogen Life

Technologies). Recombinants were identified by blue/white colony selection on
ampicillin-containing LB agar plates.
Preparation of Plasmid DNA and Sequencing
Clones positive for the expected 2.1 Kb insert (based on primer design) were

selected by colony PCR. Colony PCR amplification was carried out for 30 cycles of 94°C
for 30 s, 51 C for 30 s, and 72°C for 2 m. Plasmids of selected clones were purified

using the SV Minipreps DNA purification system (Promega). The purified plasmids
were subjected to cycle sequencing reactions composed of 2pl Big Dye Terminator V3.1

(Applied Biosystems); 4 pl purified plasmid DNA (35 ng/pl); 2 pl Bigdye terminator
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buffer; and 2 pl (0.8 pM) gene-specific primer. All cycle sequencing reactions were

carried out as follows: initial denaturation at 96°C for 1 m, followed by 30 cycles of 96°C
for 5 s, 50°C for 10 s, and 60°C for 4 m (Sanger et al., 1977). The resulting cycle
sequencing products were submitted for sequencing by the ABI377 (Applied Biosystems)
automated sequencer at the FIU DNA Sequencing Core facility. Clones were subjected

to cycle sequencing using M13 forward and reverse primers (Table 1); gene specific
primers were constructed from resulting sequences to further sequence the entire gene.
All sequencing primers were designed to overlap at the 3' end of each reading frame by
at least 100 base pairs (Figure 3). Gene specific primers used to identify and sequence

GcC8a gene are listed in Table 1.

X341

Ampiftn

FuALntI
1'8

'lone~

Figure 3: Schematic of primer local and overlapping clones of GcC8cL gene.
Amplification and Cloning of Full-Length GcC8a
A full-length GcC8ct transcript was obtained by long-PCR using primers C8aESFP2 and C8a-ESRPl1 that were designed to the 5' and 3' UTR of the assembled
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sequence generated from overlapping clones (Figure 3). Amplification was carried out for
38 cycles: 94°C for 30 s, 60°C for 30 s, and 70°C for 3 m. The PCR mixture was

composed of 1 pl of each primer (10 pM), 45 pl PCR Supermix High Fidelity (Invitrogen
Life Technologies), and 3 pl cDNA. The PCR product was run on a 1%

agarose gel with

ethidium bromide. The band of expected size was cut out, gel-purified, cloned, and

sequenced as described in the cloning procedure employed for the preparation of plasmid
DNA and outlined above. Clones positive for the 2.5 kb insert were selected by colony
PCR.
Sequence Compilation and Phylogenetic analysis
The full-length GcC8a nucleotide sequence was assembled from over-lapping
clones (Figure 3) and translated to the corresponding amino acid sequence in the BioEdit

biological sequence alignment editor for Windows 95/98/NT/2000/XP (Hall, 1999).
Using gene specific primers a complete full-length GcC8a transcript was identified. The

identities of positive clones were established using the Basic Local Alignment Search
Tool (BLAST) search engine (Altschul et al., 1990). Identity and similarity percentages
were calculated using alignments constructed in ClustalW (Thompson et al., 1994).
Calculations were made by manually counting identical and similar amino acid residues.
Multiple alignments for phylogenetic analysis were constructed using the ClustalX

program (Thompson et al., 1997). This alignment was then used in the PAUP* program
(Phylogenetic Analysis Using Parsimony, Swafford DL, 2002) to construct a phylogeny
using the neighbor joining algorithm (Saitou and Nei, 1987) under the default settings.
Confidence in the branch points was validated by 1000 bootstrap replications. Sequences
for other species were obtained from GenBank.
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Molecular Analyses
Molecular modules were determined by studying and comparing alignments
created by ClustalW of GcC8a sequence and C8a sequences of other taxa. Potential Nlinked glycosylation sites were predicted by the presence of the amino acid sequon N-X-

[S or T] (Marshall, 1974), where X is any amino acid, followed by a Serine (S) or
Threonine (T) residue (Figure 4). Potential C-mannosylation sites were identified by
searching for the sequon W-X-X-W-X-X-W, where X is any amino acid (Hofsteenge et
al., 1999). Hydrophobicity profiles were generated under the default settings of the Kyte

& Doolittle (1982) algorithm in the BioEdit program (Hall, 1999).
Southern Blot Analysis
Southern blot analysis was employed to determine GcC8a gene copy number.
Southern blots were developed using a nylon membrane (Hybond N+ , currently GE
Healthcare) that had previously been probed by a DIG labeled probe for another shark
complement gene. The following describes how the membrane for the first probe was
constructed, how this initial DIG-probe was removed, and the membrane was further

hybridized with a probe designed specifically for GcC8a.
DIG-probe synthesis
DIG-labeled probe was synthesized using the PCR DIG Probe Synthesis Kit
(Roche) to detect copies of the GcC8a gene in restriction enzyme digests of shark
genomic DNA using the enzymes BamHI, EcoRI, HindIIl, and PstI. Using the pattern of

human C8a intron/exon as a template, the primer set C8ASAZNFP3 and C8ASAZNRP1
was designed to cover a 226 nucleotide sequence that did not extend across C8a introns
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(Morley and Walport, 2000). A plasmid (4 ng/pl) containing the full-length GcC8a
sequence was used as the template for PCR reaction. Amplification consisted of 35

cycles of 95°C for 30 s, 54°C for 30 s, and 70°C for 30 s.

Table 2: DIG-Labeled probe PCR reaction mixture. All buffers, stock, and enzymes

provided by PCR DIG Probe Synthesis Kit (Roche).
Reagent

DIG-Probe

Unlabelled Control

Autoclaved water
PCR Buffer
PCR DIG label mix

16.625 ul
2.5 ul
2.5 ul

16.625 ul
2.5 ul
None

dNTP stock

None

2.5 ul

Forward Primer

1 ul

l

Reverse Primer

1 ul

M0uM

Enzyme Mix
Template DNA
Total

0.0375 ul
1 ul of 4 ng/ul
25 ul

uM

1 ul lMuM
1 ul

M0uM

0.0375 ul
1 ul of 4 ng/ul
25 u

Restriction Enzyme Digestion
Shark genomic DNA (711 ng/pl) was digested with restriction enzymes BamHI,
EcoRI, HindIII and PstI at 37°C for 21 h. The restriction enzyme digestion mixture

consisted of 300 pl of 0.2 X TE Buffer (Invitrogen Life Technologies); 37.5 pl RE Buffer
3 (Invitrogen Life Technologies); 30 pl (711 ng/pl) shark genomic DNA; and 8 pl (10
units/pl) restriction enzyme (Invitrogen Life Technologies).
Ethanol Precipitation
Post-digestion, the nucleic acid was subjected to ethanol precipitation by adding
625 ul of 100% ethanol to each tube. The tubes were vortexed and incubated at room
temperature for 10 m. The digested DNA was further centrifuged at 3250 x g at 4°C for
20 m. The supernatant was then discarded and 1.2 ml of 70% ethanol added and vortexed.
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This mixture was centrifuged at 3250 x g for 5 m at 4°C and the supernatant discarded.
The tubes were then inverted on clean tissue paper for 20-27 m to air-dry the DNA.
Finally, the precipitated DNA was re-suspended in 80 pl of 0.2X TE buffer and stored at
4°C until Southern Blot analysis was performed.

Electrophoresis of Digested Shark Genomic DNA
The digested shark genomic DNA (5 pg/lane) was electrophoresed in 0.8%
agarose gel at 22 V for 10 h. The gel was then stained in 300 ml (0.5 pg/ml) of ethidium

bromide in 1X TAE buffer. The digested DNA was further cut by immersing and
agitating the stained gel in 500 ml of 0.25 N HCl at room temperature for 20 m. The
DNA on the gel was denatured to keep the DNA fragments single stranded in 0.2 M
NaOH/0.6 M NaCl for 15 m at room temperature twice. The gel was then rinsed with
deionized water. The DNA from the gel was transferred onto a Hybond N+ nitrocellulose
membrane by capillary action blotting for 17 h at room temperature. The DNA was
immobilized under the "optimal" (120 mJ) setting option of the UV cross-linker.
Reprobing Southern Blot
As stated earlier, a previously probed membrane was used after stripping the
membrane. To remove existing probe the used membrane was rehydrated in ddH 2O for
2-3 m, then submerged in 0.2 N NaOH/0.1% SDS probe removal solution under agitation
at 37°C for 10 m. The membrane was removed from the solution, washed a second time
with the probe removal solution, and incubated a second time. The membrane was then
equilibrated by agitation in 2X SSC at room temperature for 2-3 m. The membrane was

placed in a hybridization tube with 5 ml of 42°C prehybridization solution (5XSSC, 2%
milk, 7% SDS, 0.05 mg/ml salmon sperm DNA in ddH 2O) and incubated in a
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hybridization chamber at 42°C for 2-4 h. After prehybridization, hybridization solution
(5 ml prehybridization solution and 10 pl DIG-labeled probe) was added to blot in the
hybridization tube and incubated overnight (16-18 h) at 42°C. The membrane was

removed from the hybridization tube, placed in a wash solution (2X SSC, 0.1% SDS in
ddH 20), and agitated for 15 m at 42°C. This wash step was repeated two times. Then,
stringent washing was performed twice in 0.1xSSC and 0.1% SDS for 30 m at 42°C.
Then, DIG buffer 3 was added to the membrane and agitated for 5 m at room
temperature. The membrane was heat-sealed in a plastic bag with 1 ml LUMI-PHOS

Plus solution (Lumigen), wrapped in foil, and incubated for 45 m at 37°C. Finally, under
red light, x-ray film was placed along with the membrane in a film cassette for 3 h. After
incubation, the film was removed and placed in developer solution (Kodak) until band
formation was visualized. The x-ray film was dipped in stop solution (20% acetic acid in

ddH 2O) for 2 m, and finally into fixer solution (Kodak) for 3 m. The film was washed by
running water and then hung to air dry.

GcC8a Gene Expression Analysis by RT-PCR
As described, the first-strand cDNA that was synthesized from each tissue was

used as a template for RT-PCR. Employing the primers NSC8A-L2 (forward) and C8ASQRP 1 (reverse) (Table 1) that span a 503 nucleotide region of the GcC8a sequence,

RT-PCR was performed under thermocycler settings of 42 cycles of 94°C for 30 s, 54°C
for 30 s, and 72°C for 50 s. Universal P-actin specific primers for

p-actin

(forward: 5'-

CTGCCATGTATGTTGCCATC -3' (nucleotide numbers, 389-408) and reverse 5'ATCCACATCTGCTGGAAGGT-3' (nucleotide numbers 1051-1070) were run
simultaneously as a control at the same thermocycler settings except that amplification
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was carried out for 32 cycles. PCR products were electrophoretically analyzed on a 1%
agarose gel containing ethidium bromide.
Primer Resuspension
All primers were purchased desalted from Sigma- Genosys (currently Sigma-

Aldrich) and reconstituted to 100 pM stock solutions in autoclaved sterile ddH 20. All
primers were stored at -20°C after resuspension.

SDS-PAGE
Preparation of Supernatant 1 from shark serum
Low ionic strength precipitation of shark serum was achieved by adding cold
water to reduce ionic strength of serum to 4 mS as measured by a conductivity probe.
The diluted serum was then kept on ice and swirled intermittently for 1 h. The diluted
serum was centrifuged at 1000 x g for 40 m to separate and remove the precipitated
proteins (Precipitate 1) from the supernatant (Supernatant 1), which was stored at 4°C
until used in SDS-PAGE and Western blot procedures. Lowering the ionic strength of
shark serum by dilution results in precipitation of the bulk of proteins such as Cl q and
shark immunoglobulin which can interfere with reactions in Western blots.

Sample Preparation
Samples of human serum, shark serum, and shark Supernatant 1 sample were

prepared for SDS-PAGE electrophoresis according to Table 3. Physiological saline was
used when samples were diluted as described in Table 3. Gels designated for Western
blot analysis were loaded with pre-stained molecular weight standards while gels that
were to be stained with Coomasie blue were loaded with unstained protein standards. All
samples and reference standards were heated to 95°C in a water bath for 5 m and
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centrifuged at 8000 x g before loading; 25 pl of each sample was loaded onto a separate
lane in the gel.

Table 3: SDS-PAGE sample preparation and lane allocation
Lanes

1
SS
1:50

ul Serum/Sptl
ul Physiological Saline

1
19

Sample
Dilution

2
3
SS-R Sptl
1:50 None

4
Sptl-R
None

5
HS
1:50

6
HS-R
1:50

20
None

0.66
19.34

0.66
19.34

7
BRPS

Sample

ul R buffer

ul NR Buffer

1
19

20
None

5

5

5

5

5

5

NR: non-reduced, R: reduced, SS: shark serum, Sptl: Supernatant 1, HS: human serum,

BRPS: Broad Range Protein Standards
Using Bio-Rad Criterion electrophoresis cell with Bio-Rad Model 200/2.0 power
supply, gels were run in 1X tris-glycine running buffer at 200V until the dye front had
migrated to the end of the gel. When the dye front reached the bottom of the gel,
electrophoresis was halted and the gel assembly dismantled. The left side of the gels was
nicked to show the direction in which the gel was loaded, the gels were then immersed in
Fermentas PageBlue staining solution for 5 m and rinsed in water until most of the dye
was removed. After destaining (20% methanol, 10% acetic acid), the gels were
photographed, then wrapped in one layer of cellophane and vacuum-dried on a Model

543 gel dryer (Bio-Rad).

Western Blot Protocol

Four pairs of SDS-PAGE gels were run as described above. One gel of each pair
was used to stain as described to visualize all protein bands of each sample, while the
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other was used to blot. The blotting gels were rinsed in water and assembled into the
blotting sandwich. The sandwich was assembled as follows: the cassette was laid black
side down. A fiber pad was placed on the black side, then filter paper, the gel, the
nitrocellulose membrane, more filter paper, and last, a fiber pad. The cassette was closed
and placed in the transfer chamber. Prior to assembly, all sandwich materials
(nitrocellulose membrane, filter pads, and filter paper) were equilibrated in Nupage
transfer buffer (Invitrogen Life Technologies). An ice block was added to the chamber
along with a stir bar to prevent damage to the blot from the heat generated by the
electrical current. The chamber was filled with transfer buffer, placed on a stir plate, and
connected to the power supply. The apparatus was subjected to 100 V for 1 h. To
confirm complete protein transfer from gel to membrane, the sandwich was disassembled

and the gels were stained with Coomasie blue which would stain proteins that did not
transfer and remained in the gel. All washing and incubations were subjected to agitation
to ensure adequate homogenous covering of the membrane and prevent uneven binding.
The membranes were immersed in blocking solution of 5% milk (Carnation) for 1.5 h in
a dark container. The solution was replaced with fresh blocking solution and the blots
were left at 10 0C overnight. The blocking solution was removed and wash diluent buffer

(WDB: 200 ml 1XTBS, 2 g instant milk, 100 pl Tween 20) was added to the membrane
and agitated for 10 m. This step was repeated three times. Then, 10 ml of primary

antibody solution (lXTBS, 1% milk, and 1:200 diluted goat anti-human C6, C7, C8, or
C9 antibodies purchased from Quaigen) was added and agitated for 3 h. The blot was
then washed with WDB for 20 m twice at room temperature, then 10 ml of secondary
antibody solution (1XTBS, 1%

milk, and peroxidase-tagged rabbit anti-goat
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immunoglobulin (Ig) secondary antibody (1:500)) was added to the blot and incubated for
1 h with agitation. The secondary antibody solution was decanted and the blot was
washed twice with WDB for 10 m each time. The protein blot was then developed by the
addition of BioRAD HRP (horse radish peroxidase) Conjugate Substrate kit until reactive
bands appeared. Precaution was taken not to allow development to proceed for too long
in order to avoid and minimize non-specific reactions.
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CHAPTER IV.
RESULTS
Cloning and Sequence Analysis of the Full-Length GcC8a cDNA
A 2341 nucleotide sequence was constructed from overlapping clones (Figure 3 and 4)
that included the 3' and 5' UTRs. Table 1 lists the primers used. From these overlapping
clones a single cDNA sequence was determined (Figure 3 and 4). Gene specific primers
designed C8a-ESFP2 and C8a-ESRP1, were designed based on the compiled sequence
and used in PCR amplification (Frohman et al., 1988) to generate a mRNA transcript
representing the full-length shark C8a gene. Several clones representing a single full-

length cDNA sequence with the 3' and 5' UTRs and high homology to C8a of the
human, mouse, rat, rabbit, and pig were identified. The nucleotides (1770) of the coding
region were translated using the BioEdit program (Figure 4) into 589 amino acid
residues.

GcC8a Percent Identity and Similarity Across Taxa
Using the computer software ClustalW, the deduced GcC8a amino acid sequence
was aligned with other known C8a amino acid sequences of the human, mouse, rat, pig,
and rabbit (Figure 6). The percentage of amino acid identity and similarity between
GcC8a and C8a sequences from other species was calculated (Table 4). The average
amino acid sequence identity between the nurse shark C8a gene and human, mouse, rat,
pig, and rabbit known C8a sequences ranged from 38.7 - 47.4% identity and 65.4 -

78.4% similarity.
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1

AAAAAATATTATTACACTGCATGAAGAATGAATATGTTTTTGAGCTGCTTCTCAACTTTTGCATGCCTGCTGTTTTTTACTCATTTTGCC
90
M F L
S C F
S
T F A
C L
L F F
T H
F A

91

AATTCGAATCAGATCAGCAACAGTTCAAAACATTGTTGCACGCATCACTCTGGCCGAAAAATCCGAAGTGTAGTCCCACTTGACTGTCAA
N S
N Q
I
S N S S K H
C C T
H Q
S
G R
K I
R
S
V V
P L
D C Q

181

CTTGGCCAGTGGGCACAATGGACAGTGTGTTCTCCTTGTGAAGCAAGAAAGTCCAGATATAGGAATCTGAATCGGCCAGCCATATATGGT
270
L G
Q W A
Q W T
V C S
PC
E
A R
K S
R
Y R N
L N R
P A
Y G

271

GGTAGCCAATGCATTGGATCTCTCTGGGAAGACACATCTTGTGAAACATCTGAACAATGCATACCAAAAATTAACTGTGGTGATCAGTTT 360
G
S Q
C I
C
S L W
E D
T S C
E T S
E Q
C =
P K
N
C G D
Q F

361

CAATGTAGTTCAGGTCGATGTATTAAAAGACATTTACTGTGCAATGGTGAGAAAGACTGTGCAGATGTTTCAGATGAAGAAACCTGTGAG
Q
C S
S G R C I K R H L Z C N G E K DC
A
D V S
D E E TC
E

451

TCTGACTATCCATATGAGAGAAGGACTTTCTGCAGTGACTTGTTTTTAATCCCAGGCATAGAAGCAATTATGACTGGCTATAACATCTTA 540
S
D Y
P Y E
R R
T F C
S D L
F L
I P GI
E A
I M T
G Y N
I T,

541

ATACATGACGTTGGAAGAACTGTGTTAGACACTGGGTTTGGTGGATATTGTGAATATGTGTATAATGGGGACTGGAGGGAACTGCGATAT 630
I H D V G R
V
L D T G
F G
G Y CE
Y V
Y N
CD
W
R E L
R Y

631

GACAGTGAGTGTGAACGCCTCTACTATAACGATGATGAGAAATACTACCGAAAACCATACAATTTACTCACATACCGTTTTSAGGCAATT 720
D
S E C
E R
L Y
Y N D
D E K
Y Y
R K
P Y N L
L T
Y R F E A
I

721

GCTGATTCTGGATTTACCATAGATGTTCACAATGATGTACATGAATTAATTACAGCAATGAAGCATACAGACTCCTTTGATTTTGCAGTC 810
A
D S G
F T
T D V
H N
D V H E L
I T A M
K
H T D S F D F A V

811

GGTGTGCAAGTTTCTGTTGTAAAAGCTGCTATTGCTTTTGGAGAATATTCCACATTTATTAGAAATGTATCAAGGTTTCAAGGGAAGGAT 900
G V
Q V
S V
V K A
A
I A F G E Y S T F I R N V S R F Q G K D

901

GTCAGTTTTGTTCGTGTTCGTACTAAGATTCAAACTGCTCACTTCAAAATGAGGAGATATAATTTAC PTT'GGATGAAGATATGACTCAA 990
V
S F V
R V
R T K T Q T A H F K M R R Y N L L L D E D M T Q

991

TCCCTCATGAAACTTCCAGATGAATACAATTACGGAATGTACGCTAAATTCATTGCAGATTATGGTACTCATTACTATGCTTCAGGAACA 1080
S
L M
K L
P D E
Y N Y
G M
Y A K
F
I A
D Y G
T H
Y
Y A S G
T

180

450

1081 ATGGGAGGTGTTTATGAGTTCATTCTTGTTCTGAATAAGAAGGCATTGGCAGAGTCAGATTTAACTGCATCCGAAGCTGGATTTTGCGTT 1170
M
G G
V Y
E F
I
L V
L N K
K A L
A E
S
D L T A S E A G F C V
1171 GCAGGATCACTGGGAGTAGTGGTTTCAAAAGGAACCATGGATGTGGGTGGCTCGGTAAAGGCCAAAGSTTGTAACGTAAATTGGAGCAG
A
G S
L G V
V V
S K G
T M D V G
G S V
K A
K S
C R
R K L E Q

1260

1261 AATGAACCTTCAGAAAAGTCAAGAAGCCTTGTTGAAGATGTTCTTCCACATTACTGGGAGGTGACCTGAAATCAAGTGCTGGACTATTA
N
E P
S E
K S R
S L V
E D V
L
P H V
L
G G
D L K
S S A G L L

1350

1351 GGTCATGGAA7ACCAGATGTCAAAATGTATCGGCATTGGGGTAAATCTTTGAAATACCTGCCAGCTGTCATTGACTTTGAGCTCATGCCA 1440
H W G K S L K Y L P A V T D F E L M P
D V K
M Y R
G
H I
P
1441 ATTTA7GACTTGGTGGCCAGAAGTAAACTTCAGTCTGTTGAAATCAAACAACAAAATTTAAAAAGAGCCATGGAAGAGTACTTGGTGGAG 1530
S V E I K Q Q N L K R A M E E Y L V E
K L Q
L V A
R S
I
Y D
1531 TTTCATCCCTGTAGGTGTCCTGTGTGCTATAATAATGGAAAAGCAGTTCTTCTGGACAATGTCTGTACCTGTGAATGTCTGCCTGGTTAT
H P C R C P V C Y N N G K A V L L D N V C T C E C L P G Y
F

1620

1621 GAAGGGAAAGCGTGCCAGGATACTAAACGAAAGGGGCCCACTAATGGAAATTGAGCTGTTGGTCAGGTGGTCTTCTTGCCAGAATGGT 1710
SC
Q N G
G W S
C W S
N G N W S
G P T
D T
K R K
G K A
C Q
E
1711 TCAAAACAGCGAACACGAAGCTGTAACCATCCACCCCCTAAAGATGGTGGTSCTACATGCCTTGGGAAGAACACACAAACCAAGCATTGT
S K Q R T R S C N H P P P K D G G A T C L G K N T Q T K H C

1800

1801 TAAAACAAAATAATACCTCTGGCATTTTGGCCCGTTGAA7TATTTGCTTTTGGGTGATCATTATTTTCTTTGAGTATAGATGAATATGAG 1890
1980
GTATAGGCAACATTTTGAAATACTACTCTGTGTTCTTTGTTGATTTCTTAAATSTAATAATTTGASATGTATTCATTGATGTGAAACA
2070
TTTGAACTGACGTGACAAGAATTATCCTTTATTGAAGAAAGATTAAAACTGATTTGTSTGCATTAATGTTTGGCCAGGAAGCTTGTTCAC
IGAA T 2160
ACTTCCAGGACCATCATTACCAGTTGATTGGTCAACATACTGCAATGAATT ATGOSASTCAGCATTGCAAAGACCT'AYT IZT'GA
ACATGTCACCTTGATATCTGATCCATTGTTTTCTTTACAGCAGGAACACAATCTAT3AAGAAAATATAAAATAAA'CAATATATT7 2250
2341
2251 AGCAGCATTAAATTCTGTACAGGATATCAAAGCAGTTATGATTCCTAT-ACTAATAAAGAGATGCCA

1891
1981
2071
2161

Figure 4. Nucleotide and deduced amino acid sequence of GcC8a cDNA. The nucleotide
sequence is above and the deduced amino acid sequence is below. Underlined bold letters
indicate initiation codon, stop codon, and polyadenylation recognition signal, and the
polyadenylation tail sequence. Putative N-linked glycosylation sites are indicated by
bold, italicized N's and mannosylation sites indicated by bold, italicized sequences
beginning and ending with W.
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Table 4. Percent Identity and Similarity between the deduced amino acid GcC8a
sequence and C8a homologues of other taxa

Organism
Human
Rabbit
Chicken
Mouse
Rat
Pig
Frog
Rainbow Trout

Identity
41.4
40.9
36.9
42.6
40.6
44.0
47.4
38.7

Similarity
76.2
76.9
65.4
78.4
72.2
77.1
77.4
70.1

Phylogenetic analysis
Multiple alignments for phylogenetic analysis were constructed by the ClustalX
program (Thompson et al., 1997) using entire protein sequences of known MAC amino
acid sequences, obtained from GenBank (Table 5) and GcC8a. This alignment was then
used by the PAUP* program (Swafford, 2002) to construct a phylogeny using the

neighbor joining algorithm (Saitou and Nei, 1987) under the default settings (Figure 5).
Human, mouse, cow, cat and woodchuck perforin sequences were used as an out group.
Confidence in the branch points were validated by 1000 bootstrap replications. GcC8a
forms a clade with C8a sequences from other taxa and is sister taxa with Xenopus C8a.
The tree also shows that the C8 complex has diverged from a common ancestor with C9.

Table 5. Accession numbers correlating with sequences used in Figure 6 phylogeny
Organism
Human C6
Trout C6
Frog C6
Amphioxus

Accession
number
BAD02321
CAF22026
AAH76972
BAB47147

Accession
number
XP_356827
NP_000553
CAH65481
NP_00100901

Organism
Mouse C7
Human C8a
Trout C8a
Chimpanzee C6

5

C6
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Organism
Rabbit C8a
Chicken C8a
Xenopus C8a
Zebrafish C9

Accession
number
AAA31191
XP_426667
AAH74554
NP_001019
606

Human C7
Trout C7-1
Trout C7-2
Chicken C6
Xenopus C6
Zebrafish C6
Pig C7
Human C9
Rat C9
Trout C9
Dog C9
Flounder

CAA60121
CAD92841
CAF22025
XP 429140
AAH76972
NP_956932
NP_999447
NP_001728
NP 476487
CAJ01692
XP_536494
BAC76420

Dog C6-1
Dog C6-2
Rat C7
Chicken C7
Flounder C7
Shark C8a
Trout C83
Trout C9
Mouse C9
Killifish C9
Human perforin

XP_868028
XP_536488
XP_226803
XP 424774
BAA88899
EF654112
AAL16647
P06682
NP_038513
AAR87007
AAA60065

Human C8a
Human C8p
Cow C8p -1
Cow C8p -2
Dog C8
Mouse C8p
Flounder C8p
Fugu C9
Grass Carp C9
Flounder C9
Orangutan C6

NP_000553
NP_000057
XP 590870
XP_870144
XP_536694
NP_598643
BAA86877
AAC60288
AAS76086
BAA86878
BAD02323

perforin
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Figure 5. Phylogenetic analysis of MAC amino acid sequences across taxa. Alignment
completed in ClustalX and phylogenetic tree generated by PAUP rooted on perforin from
three taxa. Accession numbers of the sequences used to construct the tree are listed in the

Table 5.
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Multiple Alignment and Sequence Analyses
Using the computer software ClustalW, the shark C8a-deduced amino acid
sequence was aligned with other C8a amino acid sequences of human, mouse, xenopus,
and trout (Figure 6). The shark C8a sequence contains 33 cysteine residues of which 29
are conserved between the shark and human sequences. These residues are potentially

capable of forming, through disulfide bonds, the characteristic C8a cysteine backbone
suggesting a similar folding pattern and function to mammalian, amphibian, and teleost
C8a. The GcC8a sequence includes the cysteine residue at 164 in human C8a and forms

the disulfide bond with C8y (Brickner and Sodetz, 1985). The nurse shark C8a sequence
also conserves the cysteines that correspond to C 324 and C 34 9 in human that are proposed

to form a disulfide bridge (Peitsch et al., 1990) (Figure 6). The multiple alignment also
confirms the presence of the indel (human aa 159-175, shark aa 198-207) exclusive to
C8a (Figure 6 and 7).
Analysis of the primary structure showed that GcC8a has a modular structure
consistent with that of C8a of other taxa examined (Figure 8). The MAC-conserved
modules identified in GcC8a are similar to those of mammalian species. The two T1
repeats, LA repeats, EG, and MACPF segments are present in GcC8a and are highly
conserved (Figure 6 and 8).
28
Two potential N-linked glycosylation sites, at ASN 26 (in the 5' UTR) and ASN 1

(Figures 4 and 8), were identified in the sequence. The sequence was also examined for
potential mannosylation sites; two were identified: one in the first T1 repeat in the pattern
of WxxW amino acids 532-565 WAQW and the second site in the WxxWxxW motif and
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Figure 6. Full-length amino acid sequence alignment in ClustalW of GcC8a with
homologues from other vertebrates: Homo sapiens, Mus muluscus, Xenopus tropicalis,

and Oncorhynchus mykiss. The two conserved cysteine residues that are predicted to
form a di-sulfide bridge and the indel sequence are highlighted in bold italics.
Legend:
* residues conserved in all six proteins
strong group conservation
. weak group conservation
A cysteines conserved between mammalian C8a and GcC8a
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y C8y disulfide bond
N putative N-linked glycosylation sites
_ putative C-mannosylated sites

RYDSTCERLYYGDDEKY
RYDSECERLYYNDDEKY

Human C8 alpha Indel
Shark C8 alpha Indel

****

Trout C8 alpha Indel
Shark C8 alpha Indel

******

*****

RKLIYDPFCENLHYNEDEKN
--- RYDSECERLYYNDDEKY
**.

Xenopus C8 alpha Indel
Shark
C8 alpha Indel

**.***:***

RYEPVCEQMYYSDEEKY
RYDSECERLYYNDDEKY
**:.

**::.**.***

Figure 7: Alignment comparison of shark C8a insertion/deletion sequences (indel) with
those of other taxa
* residues conserved in all six proteins
strong group conservation
. weak group conservation
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y C8y disulfide bond
N putative N-linked glycosylation sites
_ putative C-mannosylated sites

2W

amW

517

s7

C..

Schematic representation of the organization of modules/domains 5'

-

3' direction in

GcC8ct shows it to be similar to that of human C8a in domain architecture: Ti repeats
(U), LA4), MACPF (U), and an epidermal growth factor region ($). Potential Nlinked glycosylation sites are featured as stalkcircle with an N and predicted Cmannosylation sites have a C. The GcC8ci indel was aligned in ClustalW with the human
C8L indel. Asterisk (*) denote residue identity and period (.) indicate similar residues.
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located toward the end of the sequence in the final T1 repeat domains at amino acids 547553 in the shark sequence in the pattern of WSCWSGW (Hofsteenge et al., 1999).

A Kyte and Doolittle (1982) hydrophobicity analysis comparing GcC8a to human C8a
was made in the BioEdit program (Hall, 1999); the results are shown in Figure 9. The

GcC8a hydrophobicity profile suggests consistent similarities in the hydrophobic regions
with the exception of regions spanning amino acids 140-190 which lies between the LA

and MACPF modules, and amino acid stretches 380-395 and 462-470 within the
MACPF domain. These amino acid stretches are more hydrophobic in the shark
implying that GcC8a has the ability to traverse a membrane in a similar fashion as

human C8a.
Gene copy analysis of GcC8a
Southern blot analysis was performed to determine the gene copy number of

GcC8a in the shark genome. A single hybridizing band was detected in each of the DNA
digests (enzyme digestion by BamHI, EcoRI, HindIII, and PstI), indicating a single gene
copy of C8a in the shark genome (Figure 10).
Tissue Expression of GcC8a
The expression of GcC8a mRNA in tissues of the nurse shark was detected by

RT-PCR (Figure 11). This semi-quantitative analysis revealed distinctly high levels of
GcC8a transcripts in the liver, which is the primary tissue of complement protein
synthesis in most organisms. The level of expression was similar to that of the

p-actin

control. GcC8a synthesis, albeit at lower levels, was detected in all tissues examined
(kidney, brain, intestine, ovary, muscle, heart, pancreas, erythrocytes, and leukocytes),
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except for the spleen, where no expression was detected. This semi- quantitative analysis
shows that nurse shark muscle tissue and erythrocytes have the highest levels of GcC8a
synthesis after liver and smaller amounts in kidney, brain, intestine, ovary, heart,
pancreas, and leukocytes. P-actin expression, included as a positive control, was
relatively uniform in all tissues examined.

Kyte & Dooittle Scale Mean Hydrophobicity Profle
Scan-window size = 13

II

iij-

t~~~ <-2
Li P
0

40
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2220026
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360 3604604204404505

00
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Figure 9: Molecular analysis: Hydrophobicity profile of shark C8a (grey) and human
C8a (black) using the Kyte & Doolittle scale computed in the BioEdit program
Western Blot Analysis
Western blots were used to determine, using cross-reactive antibodies, the
presence in shark serum of proteins analogous to mammalian MAC proteins. Blots were

developed using goat anti-human sera to C6, C7, C8, and C9 as the primary antibody.
The secondary antibody was a rabbit anti-goat tagged with HRP.
Western blot using Anti-human C9 antisera
The Western blot using goat anti-human C9 (Figure 12) as the primary detection

antibody revealed reactive bands above 250 kDa under reducing (R) and non-reducing
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(NR) conditions. This could possibly be due to cross-reactivity between the anti-human
C9 antibody and aggregated poly-C9 of SC5b-9. There was also a reactive band at 71

1

2

3

4

5

23.1Kb

9.42Kb
6.56Kb

4.36Kb

2.32Kb
2.03Kb

Figure 10. Southern blot analysis. Genomic DNA from shark whole blood was isolated
and digested with the restriction enzymes, BamH I (Lane 2), EcoRI (Lane 3), HindIII
(Lane 4), and PstI (Lane 5), electrophoresed, transferred to a nylon membrane and
subjected to hybridization with a DIG- labeled probe. A lambda DNA/Hind III-digests
DNA mass marker was run in lane 1, the scale is displayed to the right of the blot.

kDa in human serum under both reducing and non-reducing conditions, which
corresponds to the molecular weight of human C9. In addition, in the reduced sample of
human serum a band at -40 kDa was detected. Reduced and non-reduced samples of
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shark serum and supernatant 1 showed bands at 49 kDa and in the NR shark serum
sample a band at 68 kDa was revealed which may correspond to shark C9, suggesting
that that the shark molecule is slightly smaller than the human homologue.

K S E L I

O

M H P R W

(3-actin ricon iio

Figure 11. Tissue expression of GcC8a. RT-PCR analysis of GcC80c expression in
shark kidney (K), spleen (S), brain (B), liver (L), intestine (I), ovary (O), muscle (M),
heart (H), pancreas (P), erythrocytes (E), and leukocytes (L). Expression of P-actin in
tissues was amplified as the positive control.

Western blot using antihuman C8 antiserum

Human serum under NR conditions showed a band at 151 kDa, which represents
the human C8 trimer. Two bands were also detected in the non-reduced human serum
sample at 60 and 62 kDa that most likely represent C8a and

p subunits.

Therefore, under

NR conditions, the full oligomer was detected along with its individual a and

p

counterparts. Under reducing conditions, there were two bands at 60 and 62 for the a and

p components

of human C8. Adding DTT reduced the oligomer completely to its a and

P counterparts.

In the lanes with shark serum and sptl, both under-reducing and non-

reducing conditions, a faint band was present at 64 kDa, signifying either GcC8a, a C8P
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-like component, or possibly both, since in mammals they are of similar size. Under the
NR conditions, a faint band is seen at ~185 kDa in all lanes with shark protein.
Shark Serum R
Shark Seun NR

Shark Suprrratent 1 R
Shark Superrnatent 1 NR
Human S.-rum R
Human Serum NR
ader

150 kDa

100 kDa

75 kWa

Shark C9

37 kDa
k1)a
25

Figure 12. Western blot of C9 using whole shark serum, shark supernatent 1, and human
serum samples under reducing (R) and non-reducing (NR) conditions. The blot was
developed using a goat anti-human C9 primary antibody and peroxidase-tagged rabbit
anti-goat Ig secondary antibody.
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Western blot using antihuman C7 antiserum

The Western blot yielded a single band for human serum at 110 kDa representing
human C7 under NR conditions. Since C7 is a single polypeptide a corresponding band

was expected to be present in the reduced human serum sample which was not the case.
Shark Serum R
Shark Serum NR
Shark Supernatent 1 R
Shark Supernatent 1 NR
Human Serum NR
Human Serum R
Broad Range Ladder

250 kDa

150 kDa
150 kDa

100

kDa

75 kDa

50 kDa

37 kDa

Figure 13. Western blot of C8 using whole shark serum, shark supernatent 1, and human

serum samples under reducing (R) and non-reducing (NR) conditions. The blot was
developed using a goat anti- human C8 primary antibody and peroxidase-tagged rabbit
anti-goat Ig secondary antibody.

It is possible that DTT (the reducing reagent) may have reduced intra-protein disulfide
bond(s) that changed the conformation of human C7 protein, obscuring the epitope that
the anti-human C7 antibody would recognize. Furthermore, no reactive bands appeared
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in any of the shark samples suggesting that either the antibody did not recognize and
cross-react with a corresponding C7-like shark protein or a C7 homologue is absent in

shark serum.
Western blot using anti-human C6 antiserum:
Western blot analysis of human serum, shark serum, and shark supernatant 1

using polyclonal anti-human C6 antiserum yielded no detectable bands in any of the
samples run, including human serum. No reactivity with human serum was unexpected
and might have been due to the dilution of the primary and secondary antisera in which
the concentration of antibodies was insufficient to produce a detectable reaction.
Human Serum NR
Human Serum R
Shark Supermatent 1 NR
Shark Supermatent 1 R
Shark Serum NR
Shark Serum R
Broad Range Ladder

250 kDa

150 kDa

110 kDa C7

-00

100 kV
kDa

75 kDa

50 kDa

Figure 14. Western blot of C7 using whole shark serum, shark supernatent 1, and human
serum samples under reducing (R) and non-reducing (NR) conditions. The blot was
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developed using a goat anti-human C7 primary antibody and peroxidase-tagged rabbit
anti-goat Ig secondary antibody.
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CHAPTER V.
DISCUSSION
This study is based on the hypothesis that the lytic activity of shark serum is due
to the presence of a functional lytic pathway that assembles a membrane attack complex
similar to mammalian MAC even though in the shark, it may be executed differently due
to different composition. Since there is no evidence of complement lysis and/or MAC
genes or proteins corresponding to C6 and C7 in any organisms more basal than teleosts,

the question remained what was the composition of shark MAC and whether it involved
molecules corresponding to C6 and C7. This initial study focused on the C8a subunit of
shark C8 as a first step to define shark MAC and further our understanding of the
evolution of this protein complex. Furthermore, evidence was sought to determine
whether C6 and C7 homologues could be detected in shark serum. The shark C8a gene

was cloned, sequenced, and characterized.

Western blot analysis was performed to

examine shark serum for the presence of potential C6, C7, C8 and C9 homologues.
Here we report in detail the first nucleotide and deduced amino acid sequence of a

full-length cDNA clone of a shark MAC gene homologus to C8a (Figure 4). The gene
encoding the shark C8a homologue (GcC8a) was cloned and yielded a 2431 nucleotide
sequence complete with initiation codon, stop codon, polyadenylation recognition signal,
and the polyadenylation tail sequence (Figure 4).
The cloned GcC8a sequence translated into a 589 amino acid sequence (Figure 4
and 6) that exhibits 41.3% identity (Table 4) with human C8a and has the highest percent
identity with the frog C8a sequence (47.4 %). Phylogenetically, GcC8a is sister taxa to
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frog C8a and that teleost C8a is more basal to both these genes, confirming that shark
C8a is more like that of the frog than bony fish (Figure 5). The shark C8c sequence has
more identity with mammalian (mouse - 42.6% and pig - 44.0%) and frog C8a sequences
than to trout (38.7%). The shark C8a sequence shares the lowest sequence identity and

similarity to chicken C8a - 36.9% and 65.4%, respectively. In terms of similarity, it was
surprising that the GcC8a sequence exhibited the highest similarity to a mammalian
sequence, mouse C8a, at 78.4%, and had the next highest percent similarity to frog and

pig C8x, 77.4% and 77.1%, respectively.
Alignments of the deduced GcC8a sequence reveal conservation of modules that
are characteristic to the MAC protein family. Structural analysis reveals that the MAC
modular architecture is conserved and organized in the same sequential order as

mammalian MAC proteins, specifically T1 (aa 47-100), LA (aa 104-139), MACPF (aa
289-498), EG (aa 523-534), and a final T1 (aa 544-588) module (Figure 8).
C8a is a unique member of MAC in that it contains an indel site that contains the

cysteine 164 (Cys164) residue that covalently binds C8y (Plumb and Sodetz, 2000). In
humans, the indel region is the sequence that C8y associates with, even when Cys16 4 is
replaced by a glycine residue, meaning that there is sufficient biochemical attraction in
the indel amino acid composition to bind C8y non-covalently (Plumb and Sodetz, 2000).
Multiple alignment (Figure 6) shows that the corresponding Cys16 4 as well as the region
corresponding to human indel is conserved, which indicates that GcC8a is a C8a
ortholog and shark is the most basal organism to have this unique sequence. The shark
indel (aa 198-207) is located between the LA and the MACPF domain and contains the
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conserved cysteine residue at position 203, suggesting that GcC8a may occur as a
disulfide-linked a-y dimer. This region is highly conserved between human and shark

(Figure 6-8), with 88.2% identity and 94.1% similarity to the human indel sequence. This
conservation of structural similarity as well as high conservation of the sequence
responsible for the non-covalent binding to the C8p subunit further suggests that GcC8a
might work as a trimer as C8 does in other organisms. It should be noted, however, that

homologues of C8p and C8y have yet to be described in the shark.
In humans, it has been demonstrated that all MAC proteins and perforin have two

conserved cysteine residues (C7: Cys3 17 and Cys333 ,C9: Cys358 and Cys383 , C8a:
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and

Cys370, C8b: Cys 324 and Cys 34 9, perforin: Cys236 and Cys 258 ) that form a disulfide bridge.
The loop formed by this bond is suspected to be outside the membrane when human
MAC is inserted into the target cell (Peitsch et al, 1990). These two pertinent cysteine

residues are present in GcC8a (highlighted in black in Figure 6) and suggest a similar
functional role.

All cysteine residues of human C8a form intra-molecular disulfide bonds with the
exception of Cys 6 4 , which forms an intermolecular disulphide bond with Cys40 in C8y

(Slade et al, 2006). The MAC proteins are rich in cysteine residues, and the multiple
alignment (Figure 6) demonstrates that a total of 29 cysteines are conserved between
elasmobranch and mammal suggesting that GcC8a potentially capable of forming,
through disulfide bonds, the characteristic C8a cysteine backbone suggesting a similar
folding pattern and function to mammalian, amphibian, and teleost C8a. GcC8a,
however, is more cysteine-rich as it has four extra cysteine residues located toward the N-
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terminal of the sequence in the leader peptide region that are not likely to be involved in
GcC8a function.
Examining potential glycosylation conservation in GcC8L is interesting for two
reasons: 1). Conservation of glycosylation sites between evolutionarily distant creatures

can help confirm that GcC8u is indeed the shark C8u homolog and 2) gylcosylation
plays an important role in biological activity, because elements like glycan location can
play a role in protein folding and signal response and they structurally can interfere with
activation site exposure (Wells et al., 2001). The GcC8a sequence contains two putative
N-linked glycosylation sites, identified at positions different from that of mammalian
C8a which has two potential N-linked glycosylation sites, at ASN5 and ASN385. In
humans, the latter is the only one suspected to actually be glycosylated (Morley and
Walport, 2000). The shark sites are upstream of those in human C8a in amino acid

number due to the difference in length between shark and human C8a; however, the
shark glycosylation site is likely analogous to the human one in that the region it is in is

conserved and is in the same module. The first potential N-linked glycosylation site in
human C8a is located in the T1 module, whereas in the shark it is absent from any
module and is present in the sequence upstream of that module in the 5' UTR region and,
therefore, is probably not of functional significance. The second N-linked glycosylation
site for both human and shark is located in the perforin-like segment, which has very high
sequence conservation between mammal and shark. Two potential C-mannosylation sites
were identified in the shark C8a sequence in the T 1 repeats and are highly conserved in
all orthologs examined (Figure 6 and 8): WAQW (aa 53-56) located in the first T1
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module and WSCWSGW (aa 547-553) in the second T1 module at the C-terminal end of
the molecule. As stated above, the location and distribution of glycans in the molecule is
important since glycosylation can contribute to protein folding and signal response

(Wells et al., 2001).
Based on the size of the coding region and not accounting for potential

glycosylation of GcC8a, the predicted molecular weight is likely to be higher than that of
human C8a (589 aa versus 554 amino acid residues, respectively), which also has fewer
potential N-linked glycosylation sites. Shark C8a also contains a mannosylation site that
is absent in the human molecule. An earlier study (Jensen et al., 1981) estimated, from
partially purified shark C8, a molecular weight closer to 185 kDa; human C8 mature

protein is 152 kDa. However, the structural differences noted could account for the
higher estimated molecular size of shark C8. It is also possible that the C8y homologue
in shark is a larger molecule contributing to the overall higher molecular size of shark C8.

Comparing the hydrophobicity profile of GcC8a with that of human C8a shows
consistent similarities in the hydrophobic regions with the exception of regions spanning
amino acids 140-190 which lies between the LA and MACPF modules, and amino acid
stretches 380-395 and 462-470 within the MACPF domain. The distribution and
position of hydrophobic regions through the entire coding region reveal that GcC8a has
the physico-chemical properties to function in a manner similar to C8a; that is, it most
likely participates in hydrophilic-amphiphilic transition and contributes to the assembly
and anchoring of a MAC-like macromolecule into target membranes. These amino acid
stretches are more hydrophobic in the shark implying that GcC8a has the ability to
traverse a membrane. Although there are small differences in the hydrophobicity profiles
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of human and shark C8a, complement of both species still achieves MAC lysis. The
lesions formed by shark MAC are smaller in diameter than those formed by mammalian
MAC. Mammalian MAC lesions are 100 Angstroms in diameter. Membrane holes
produced by shark MAC are 80 Angstroms in diameter, i.e., a difference of 20
Angstroms. However, ultra-structural studies of shark MAC lesions show them to be

indistinguishable from those made by guinea pig complement (Jensen et al., 1981).
To assess gene copy of GcC8a, Southern blot analysis was performed. GcC8a
exists as a single gene in the shark. Since C8a and C8p of mammals and other vertebrate
species (teleosts) are very similar in sequence homology, extra care was taken to design a
Southern blot probe to correspond to a region of C8a that did not overlap with any
sequence in C8p (should such a homologue be present in the shark) to ensure that the
Southern blot data reflects gene copy of GcC8a only. In several teleost species, some

complement genes are present in several isoforms (Kato et al., 2003; Kuroda et al, 1996;
Nakao et al., 2002; 1998; Sunyer et al., 1996, 1997,1998; Chondrou et al., 2008; Gongora
et al., 1998; Papanastasiou and Zakardis, 2005; Papanastasiou et al, 2007). This may be
due to a suspected third round of genome duplication occurring during the emergence of
bony fish (Ohno, 1970). Similarly, in elasmobranchs certain complement genes are
present in multiple forms, such as GcC3-1 and GcC3-2 (Smith, unpublished); GcBf/C2-1
and 2 (Shin et al., 2007); and GcIf-1, -2, -3 and -4 (Shin et al., 2009) in the nurse shark
and TrscBf-A and -B in the banded houndshark (Triakis scyllia) (Terado et al., 2001;
2002). Thus far there has been no evidence of MAC genes having multiple isoforms in
any organism so far studied, and the phenomena of multiple gene copy of complement
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genes seems to be sequestered to the genes encoding proteins of the three activation

pathways (CP, AP, LP).
To examine the expression profile of GcC8a, RT-PCR revealed that GcC8a is
synthesized by several tissues in the shark, with the highest expression in the liver. Other
tissues that synthesized GC8Ca were kidney, brain, intestine, ovary, muscle, heart,
pancreas, erythrocytes, and leukocytes. Interestingly, the expression in peripheral blood
cells is higher in erythrocytes than in leukocytes, which indicates that nucleated
erythrocytes of shark are transcriptionally active. Multiple organ/cell expression of C8a
is not seen in mammals, where C8a is synthesized primarily in the liver; however, in
other vertebrate species such as trout, C8a and C8p are expressed in several tissues

(Kazantzi et al., 2003; Papanastasiou and Zakardis, 2006). Taken together these
observations suggest that poikilothermic vertebrates synthesize complement proteins
more ubiquitously than mammals. As the complement system evolved, the tissue sites for
complement synthesis may have been reduced through evolution; however, the liver

(hepatopancreas in some species) remains likely the main site of complement protein
synthesis in vertebrates.

Phylogenetic analysis of GcC8a provides insight into the evolution of the MAC
family of proteins. Two main theories attempt to explain the evolution of this significant
gene family. Phylogenetic analyses by Mondragon-Palomino et al. (1999) using MAC
amino acid sequences supports the view that C6 and C7 are earlier in origin and were
followed by the emergence of C8 then C9. Mondragon-Palomino et al. (1999) do not
present data as to the whether C8a or R is of earlier derivation, and suggest that the
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terminal complex proteins (C6 through C9) originated from a single ancestral gene
composed of complex modular structure. They suggest that a series of gene duplications
and loss of structural modules resulted in complement proteins that make up the MAC
protein family. In contrast, Podack et al. (1991) hypothesize that, due to the similarity of
function, size, and sequence, C9 emerged first from a gene duplication event of an
ancestral gene common to both perforin and the MAC family proteins. Podack et al.
(1991) further speculate that following C9 emergence, C8, C7, and C6 successively

emerged through later gene duplication events and developed increasing modular
complexity and size. Kauffman et al.'s (1993) hypothesis is somewhat different, although

it also supports the C8/C9 faction as originators of MAC. After distance analyses of
human MAC components and perforin C8a Kauffman et al. (1993)

show that C8a and 3

have a closer phylogenetic distance to perforin than to C6, C7, and C9, maintaining that
MAC arose from a fundamental C8-like building block. The phylogenetic analysis
performed in this study supports the hypothesis that C8 and C9 are derived from a
common ancestor and represent an early duplication event that most likely predated C6

and C7. Although C6-like molecules have been described for amphioxus (Suzuki et al.,
2000) and Ciona (Wakoh et al., 2004), their role as complement proteins remains
unconfirmed. Molecular analysis of the C6-like gene described for amphioxus reveals a
5' C6 modular structure with a 3' end that is missing key modules characteristic of C6.
This could also be interpreted to be an early C8-like molecule before loss of the extra T1
module at the 5' end. Furthermore, in Ciona the C6-like gene is expressed as a cell
surface receptor and whether it has a complement function (Wakoh et al., 2004; Azumi et
al., 2003) in either organism is unknown. This amphioxus C6 gene has not been shown to
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be expressed or functional and may be C6-like only in sequence. Amphioxus C6 is also
comparable in size to C8 ((x and

P chains) and C9.

The phylogeny constructed during this investigation showed that GcC8a forms a
clade with C8a sequences from other taxa and is sister taxa with frog C8a. The tree also
shows that the C8 complex has diverged from a common ancestor with C9. Human,
mouse, cow, cat and woodchuck perforin sequences were used as an out group.

Confidence in the branch points was validated by 1000 bootstrap replications. The tree
also shows that the C8 complex has diverged from a common ancestor with C9.
According to our phylogenetic analysis C8a and C8p arose from C9 followed by C7,
then C6. Since the presence or absence of C7 and/or C6 homologues in shark remains to

be resolved it is premature to conclude that shark MAC only consists of C5b, C8, and C9.
C6 and C7 are essential to teleost, amphibian, and mammalian taxa or MAC function. If
it were to be determined that one or the other of these two proteins was in fact absent in

shark, the data would support Podack et al.'s (1991) hypothesis since C5 (Graham et al.,
2009), C8, and C9 homologues are, so far the only MAC proteins confirmed for the
shark.
The Western blot using goat anti-human C9 as the primary detection antibody
revealed reactive bands above 250 kDa under reducing and non-reducing conditions.
This is likely due to cross-reactivity between the anti-human C9 antibody and aggregates

of proteins possibly poly-C9 or SC5b-9. There was also a reactive band at 71 kDa under
both reducing and non-reducing conditions, which corresponds to the molecular weight
of human C9. Anti-human C9 antibodies detected a band at -40kDa in reduced sample
of human serum. Shark serum and supernatant 1 under reducing and NR show bands at
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49 kDa and the shark serum under NR conditions revealed a band at 68 kDa. This band
may represent shark C9 and suggests that the shark C9 may be slightly smaller than the
71 kDa human homologue.
A band at 151 kDa in human serum was revealed in Western blots using antihuman C8 antibodies which represents the human trimeric C8 molecular complex. Two
additional bands were also detected at 60 and 62 kDa representing C8 a and

P

chains.

These bands were also present in reduced human serum, however the full oligomer was

detected only in the non-reduced serum sample, suggesting that DTT reduced the
oligomer completely to its a and

P

counterparts. In the lanes with shark serum and shark

sptl, both under-reducing and non-reducing conditions, a faint band was present at 64

kDa, signifying either GcC8u, a C8P-like component, or both. Under the NR conditions,
a faint band could be seen at -185 kDa in all lanes with shark protein. The anti-human

C8 antibody did not detect C8y in the human or shark fluids, suggesting that the C8
antibody was specific for epitopes that are similar on C8a and C8P but not C8y. Whereas
C8a and

P are

so similar a single antibody would likely detect both and does in this

instance. It is not surprising that C8y was undetected as it is a lipocalin and small such

that if the shark has C8, it would not likely be detected by this test.
Only one band is visualized on the C7 Western blot in the lane with the NR
human serum at 110 kDa representing human C7. This was absent when human serum
was reduced. Although C7 does not exist as a covalently bound multimer, it is cysteine
rich and has many internal disulfide bonds which were probably reduced by the DTT.
This would change the topography of the protein and the integrity of its epitope and
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would account for non-reactivity with anti-C7 antiserum made to native protein. The
same antibody failed to detect protein in any of the shark samples. This could mean that
C7 in shark (should it be present) is antigenically distinct from its mammalian
counterpart, or that the molecule is absent in sharks.
In Western blot using antiserum to human C6 no protein bands were detected in
any of the samples run including human serum, suggesting that the antibody
concentration was too low to achieve a detectable reaction of the antibody with its target

epitope. Another possibility is that the antibody was specific for an epitope of the folded
C6 and that the human serum was sub-optimal in that the disulfide bonds had been

reduced over time or through handling obscuring the epitope the antibody was specific
for. The question of C6 homologue in the shark remains unresolved.

53

REFERENCES

Altschul S, Gish W, Miller W, Myers EW, and Lipman DJ. Basic local alignment search
tool. Journal of Molecular Biology. 1990; 215:403-410.
Atkinson JP and Frank MM. Complement-independent clearance of IgG-sensitized

erythrocytes: inhibition by cortisone. Blood. 1974a;44:629-37.
Atkinson JP and Frank MM. Studies on the in vivo effects of antibody. Interaction of
IgM antibody and complement in the immune clearance and destruction of erythrocytes

in man. Journal of Clinical Investigation. 1974b;5:339-48.
Azumi K, Santis RD, Tomaso AD, Rigoutsos I, Yoshizaki F, Pinto MR, et al. Genomic
analysis of immunity in a Urochordate and the emergence of the vertebrate immune
system: "waiting for Godot". Immunogenetics. 2003;55:570-81.
Brannen CL and Sodetz JM. Incorporation of human complement C8 into the membrane

attack complex is mediated by a binding site located within the C8b MACPF domain.
Molecular Immunology. 2007;44:960-5.
Brickner A and Sodetz JM. Function of subunits within the eighth component of human
complement: selective removal of the y chain reveals it has no direct role in cytolysis.

Biochemistry 1984; 23: 832-837.
Brickner A and Sodetz JM. Functional domains of the a D subunit of the eighth
component of human complement: identification and characterization of a distinct

binding site for the y Dchain. Biochemistry 1985; 24:4603-7.
Campbell, ID. Modular proteins at the cell surface. Biochemical Society Transactions.

2003; 31:1007-1114.
Chondrou M, Papanastasiou AD, Spyroulias GA, and Zakardis IK. Three isoforms of
complement properdin factor P in trout: cloning, expression, gene organization and
constrained modeling. Developmental and Comparative Immunology. 2008; 32:1454-66.

Dishaw LJ, Smith SL, and Bigger CH. Characterization of a C3-like cDNA in a coral:
phylogenetic implications. Immunogenetics. 2005; 57:535-48.
Frohman MA, Dush MK, and Martin GR. Rapid production of full-length cDNAs from
rare transcripts: amplification using a single gene-specific oligonucleotide primer.

Proceedings of the National Academy of Sciences. 1988; 85:8998-9002.

54

Fujii T and Murakawa S. Immunity in lamprey. III. Occurrence of the complement-like
activity. Developmental and Comparative Immunology. 1981; 5:251-9.
Gongora R, Figueroa F, and Klein J. Independent duplications of Bf and C3 complement
genes in the zebrafish. Scandanavian Journal of Immunology. 1998; 48:651-8.
Gonzalez S, Setien F, Coto E, and L6pez-Larrea C. Genetic structure and organization of
the membrane attack complement components. European Journal of Immunogenetics.

1996; 23:181-197.
G6tze O and Miller-Eberhard HJ. The C3-activator system: an alternate pathway of

complement activation. Journal of Experimental Medicine. 1971; 90-108.
Graham M, Shin D, and Smith SL. Molecular and expression analysis of complement
component C5 in the nurse shark (Ginglymostoma cirratum) and its predicted functional

role. Fish & Shellfish Immunology. 2009; 27: 40-49.
Gross PS, Al-Sharif WZ, Clow LA, and Smith LC. Echinoderm immunity and the
evolution of the complement system. Developmental and Comparative Immunology.
1999; 23:429-442.
Hadders MA, Beringer DX, Gros P. Structure of C8alpha-MACPF reveals mechanism of
membrane attack in complement immune defense. Science. 2007; 317:1552-4.
Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis
program for Windows 95/98/NT. Nucleic Acids Symposium Series. 1999. 41:95-98.
Haefliger JA, Peitsch MC, Jenne DE, and Tschopp J. Structural and functional

characterization of complement C8 gamma, a member of the lipocalin protein family.
Molecular Immunology. 1991;28:123-31.
Hofsteenge J, Blommers M, Hess D, Furmanek A, and Miroshnichenko O. The four
terminal components of the complement system are C-mannosylated on multiple

tryptophan residues. Journal of. Biological. Chemistry. 1999; 274: 32786-94.
Humphrey JH and Dourmashkin RR. The lesions in cell membranes caused by

complement. Advances in Immunology. 1969;11:75-115.
Jensen JA, Festa E, Smith DS, and Cayer M. The complement system of the nurse shark:
hemolytic and comparative characteristics. Science. 1981; 214:566-569.
Jensen JA, Fuller L, and Iglesias E. The terminal components of the nurse shark C

system. Journal of Immunology. 1973; 111:306-307.
Kato Y, Nakao M, Mutsuro J, Zarkadis IK, and Yano T. The complement component

55

C5 of the common carp (Cyprinus carpio): cDNA cloning of two distinct isotypes that
differ in a functional site. Immunogenetics. 2003;54:807-15.

Kauffman DL, Keller PJ, Bennick A, and Blum M. Alignment of amino acid and DNA
sequences of human proline-rich proteins. Critical reviews in oral biology and medicine.

1993; 4:287-92.
Kaufmann T, Rittner C and Schneider PM. The human complement component C8B
gene: structure and phylogenetic relationship. Human Genetics. 1993; 92:69-75.
Kalagiri T, Hirono I, and Aoki T. Molecular analysis of complement component of C8P
and C9 cDNAs of Japanese founder, Paralicththysolivaceous. Immunogenetics, 1999;

50: 43-48.
Kazantzi A, Sfyroera G, Holland MG-H, Lambris JD, and Zarkadis IK. Molecular
cloning of the beta subunit of complement component eight of the rainbow trout.

Developmental and Comparative Immunology. 2003; 27:167-174.
Kimberley FC, Sivasankar B, and Morgan BP. Alternative roles for CD59. Molecular

Immunology. 2007; 44:73-81.
Kolb WP, Haxby JA, Arroyave CM, Muller-Eberhard HJ. Molecular analysis of the
membrane attack mechanism of complement. Journal of Experimental Medicine. 1972;

135:549-66.
Kolb WP and Muller-Eberhard HJ. Neoantigens of the membrane attack complex of
human complement. Proceedings of the National Academy of Sciences. 1975; 72:16879.
Kolb WP and Muller-Eberhard HJ. The membrane attack mechanism of complement:
the three polypeptide chain structure of the eighth component (C8). Journal of

Experimental Medicine 1976;143:1131-9.
Kolb WP and Muller-Eberhard HJ. Mode of action of human C9: adsorption of multiple
C9 molecules to cell-bound C8. Journal of Immunology. 1974; 113:479-88.
Kuroda N, Wada H, Naruse K, Simada A, Shima A, Sasaki M, and Nonaka M. Molecular
cloning and linkage analysis of the Japanese medaka fish complement Bf/C2 gene.
Immunogenetics 1996; 44:459-67.
Kyte J and Doolittle RF. A simple method for displaying the hydropathic character of a
protein Journal of molecular biology. 1982; 157:105-32.
Lambris J, Reid K, and Volanakis J. The evolution, structure, biology and
pathophysiology of complement. Immunology Today. 1999;20:207-11.

56

Legler DW and Evans EE. Comparative immunology: hemolytic complement in
elasmobranchs. Proceedings of the Society for Experimental Biology and Medicine.

1967;124:30-4.
Liszewski MK, Farries TC, Lublin DM, Rooney IA, and Atkinson JP. Control of the

complement system. Adv Immunol. 1996;61:201-83.
Marino R, Kimura Y, De Santis R, Lambris JD and Pinto MR, Complement in
urochordates: cloning and characterization of two C3-like genes in the ascidian Ciona

intestinalis. Immunogenetics. 2002; 53:1055-1064.
Marshall RD. The nature and metabolism of the carbohydrate-peptide linkages of
glycoproteins. Biochemical Society Symposium. 1974;(40):17-26.
McLin VA, Hu CH, Shah R, and Jamrich M. Expression of complement components
coincides with early patterning and organogenesis in Xenopus laevis. International

Journal of Developemental Biology. 2008;52:1123-33.
Mikrou A and Zarkadis IK. Cloning of the sixth complement component and, spatial and

temporal expression profile of MAC structural and regulatory genes in chicken.
Developmental and Comparative Immunology. 2010;34:485-90.
Mondragon-Palomino M, Pinero D, Nicholson-Weller A, and Laclette JP. Phylogenetic
Analysis of the Homologous Proteins of the Terminal Complement Complex Supports
the Emergence of C6 and C7 Followed by C8 and C9. Journal of Molecular Evolution.
1999;49:282-9.
Morley BJ and Walport MJ. The Complement Facts Book. Academic Press, 2000. P.
123 - 130.
Muller-Eberhard HJ. Molecular organization and function of the complement system.

Annual Review of Biochemistry. 1988; 57:321-347.
Musingarimi P, Plumb ME and Sodetz JM. Interaction between the C8a-y and C8

Subunits of Human Complement C8: Role of the C8 N-Terminal Thrombospondin
Type 1 Module and Membrane Attack Complex/Perforin Domain. Biochemistry. 2002;

41:11255-11260.
Nakajima E, Itoh T, Suzuki K, Kawakami K, Takeda K, Onishi A, and Komatsu M.
Characterization, chromosomal localization, and genetic variation of the alpha subunit of
porcine eighth component of complement. Animal Genetics.1998; 29:377-80

57

Nakao M, Kato-Unoki Y, Nakahara M, Mutsuro J, and Somamoto T. Diversified
components of the bony fish complement system: more genes for robuster innate
defense? Advances in experimental medicine and biology. 2006; 586:121-38.
Nakao M, Fushitani Y, Fujiki K, Nonaka M, and Yano T. Two diverged complement
factor B/C2-like cDNA sequences from a teleost, the common carp (Cyprinus carpio).

Journal of Immunology. 1998; 161:4811-8
Nakao M, Matsumoto M, Nakazawa M, Fujiki K, and Yano T. Diversity of complement
factor B/C2 in the common carp (Cyprinus carpio): three isotypes of B/C2-A expressed
in different tissues. Developmental and Comparative Immunology. 2002; 26:533-41.

Ng SC, Rao AG, Howard OM, and Sodetz JM. The eighth component of human
complement (C8): evidence that it is an oligomeric serum protein assembled from

products of three different genes. Biochemistry. 1987; 26:5229-5233.
Nonaka M. Evolution of the complement system. Current Opinion in Immunology.

2001;13:69-73.
Nonaka M, Fujii T, Kaidoh T, Natsuume-Sakai S, Nonaka M, Yamaguchi N, and
Takahashi M. Purification of a lamprey complement protein homologous to the third
component of the mammalian complement system. Journal of Immunology. 1984;
133:3242-9.
Nonaka M and Smith SL. Complement system of bony and cartilaginous fish. Fish and
Immunology. 2000; 10:215-28.
Nonaka M, Takahashi M, and Sasaki M. Molecular Cloning of a Lamprey Homologue of
the Mammalian MHC Class 111 Gene, Complement Factor B. The Journal Immunology.
1994; 152: 2263 - 2269.
Nonaka M, Yamaguchi N, Natsuume-Sakai S, and Takahashi M. The complement system
of rainbow trout (Salmo gairdneri).Identification of the serum lytic system homologous

to mammalian complement. Journal of Immunology. 1981; 126:1489-94.
Nonaka M, Azumi K, Ji X, Namikawa-Yamada C, Sasaki M, Saiga H, Dodds AW,
Sekine H, Homma MK, Matsushita M, Endo Y, Fujita T. Opsonic complement
component C3 in the solitary ascidian, Halocynthia roretzi. Journal Immunology.

1999;162:387-91.
Ohno, S. Evolution by gene duplication. Springer-Verlag, Berlin. 1970.
Papanastiou AD, Georgaka E, and Zakardis IK. Cloning of CD59-like gene in
rainbow trout. Expression and phylogenetic analysis of two isoforms. Molecular

Immunology. 2007;44:1300-6.

58

Papanastasiou AD and Zakardis IK. Gene duplication of the seventh component of
complement in rainbow trout. Immunogenetics. 2005; 57:703-8.
Papanastasiou AD and Zarkadis IK. Cloning and phylogenetic analysis of the alpha
subunit of the eighth complement component (C8) in rainbow trout. Molecular

Immunology. 2006a; 43:2188-94.
Papanastasiou AD and Zarkadis IK. The gamma subunit of the eighth complement
component (C8) in rainbow trout. Developmental and Comparative Immunology. 2006b;

30:485-91.
Parker CL and Sodetz JM. Role of the human C8 subunits in complement-mediated

bacterial killing: evidence that C8 7 is not essential. Molecular Immunology.

2002;39:453-8.
Peitsch MC, Amiguet P, Guy R, Brunner J, Maizel JV, and Tschopp J. Localization and
molecular modelling of the membrane-inserted domain of the ninth component of human

complement and perforin. Molecular Immunology. 1990; 27:589-602.
Platteborze PL, Hobart MJ, and Sodetz JM. Physical linkage and orientation of the
human complement C8 alpha and C8 beta genes on chromosome 1p32. Human Genetics.
1996; 98:443-6.
Plumb ME, Scibeck JJ, Barber TD, Dunlap RJ, Platteborze PL, and Sodetz JM. Chimeric
and truncated forms of human complement protein C8 alpha reveal binding sites for C8
beta and C8 gamma within the membrane attack complex/perforin region. Biochemistry.

1999; 38:8478-84.
Plumb ME and Sodetz JM. An Indel within the C8a Subunit of Human Complement C8
Mediates Intracellular Binding of C8y and Formation of C8a-yBag. Biochemistry. 2000;
39:13078-13083.
Podack ER. Assembly and structure of the membrane attack complex (MAC). In:
Podack, editor. Cytolytic lymphocytes and complement: effectors of the immune system,

vol. 1. Boca Raton: CRC Press. 1988; p. 173-84.
Podack ER, Biesecker G, Kolb WP, Muller-Eberhard HJ. The C5b-6 complex: reaction
with C7, C8, C9. Journal of Immunology. 1978; 121:484-90.
Podack ER and Tschopp J. Membrane attack by complement. Molecular Immunology.

1984; 7:589-603.
Podack ER, Olsen KJ, Lowrey DM, and Lichtenheld M. Structure and function of
perforin. Current Topics in Microbiology and Immunology. 1989;140:11-7.

59

Podack ER, Hengartner H, Lichtenheld MG. A central role of perforin in cytolysis?

Annual Review of Immunology. 1991; 9:129-47.
Ramm LE, Whitlow MB, and Mayer MM. Size of the transmembrane channels produced

by complement proteins C5b-8. Journal of Immunology. 1982;129:1143-6.
Rittner C, Hargesheimer W, Stradmann B, Bertrams J, Baur MP, and Petersen BH.
Human C81 (alpha-gamma) polymorphism: detection in the alpha-gamma subunit on
SDS-PAGE, formal genetics and linkage relationship. American Journal of Human

Genetetics. 1986; 38:482-91.
Saitou N and Nei M. The neighbor-joining method: a new method for reconstructing

phylogenetic trees. Molecular Biology and Evolution. 1987; 4:406-25.
Sanger F, Nicklen S, and Coulson AR. DNA sequencing with chain-terminating

inhibitors. Proceedings of the National Academy of Sciences. 1977; 74:5463-5467.
Scapigliati G, Buonocore F, Bird S, Zou J, Pelegrin P, Falasca C, Prugnoli D, Secombes
CJ. Phylogeny of cytokines: molecular cloning and expression analysis of sea bass

Dicentrarchus labrax interleukin-1 beta. Fish Shellfish Immunology. 2001;11:711-26
Scibek JJ, Plumb ME, and Sodetz JM. Binding of Human Complement C8 to C9: Role
of the N-Terminal Modules in the C8B Subunit. Biochemistry. 2002; 41:14546-51.
Shin DH, Webb B, Nakao M, and Smith, SL. Molecular cloning, structural analysis and
expression of complement component Bf/C2 genes in the nurse shark, Ginglymostoma

cirratum. Developmental and Comparative Immunology. 2007; 31:1168-1182.
Shin DH, Webb BM, Nakao M, and Smith SL. Characterization of shark complement
factor I gene(s): genomic analysis of a novel shark-specific sequence. Molecular

Immunology. 2009; 46:2299-308.
Slade DJ, Chiswell B; and Sodetz JM. Functional studies of the MACPF domain of
human complement protein C8 alpha reveal sites for simultaneous binding of C8 beta, C8
gamma, and C9. Biochemistry. 2006; 45:5290-6.
Smith LC, Azumi K, Nonaka M. Clow LA, and Terwilliger DP. The ancestral
complement system in sea urchins. Immunological Reviews. 2001; 180:16-34.
Smith, LC, Azumi K, and Nonaka M. Complement systems in invertebrates. The
ancient alternative and lectin pathways. Immunopharmacology 1999; 42:107-120.
Smith, SH and Jensen JA. The second component (C2n) of the nurse shark complement
system: purification, physico-chemical characterization and functional comparison with
guinea pig C4. Developmental and Comparative Immunolology. 1986; 10:191-206.

60

Smith, SL. Shark complement: an assessment. Immunological Reviews 1998; 166:67-

78.
Sodetz JM. Structure and Function of C8 in the membrane attack sequence of
complement. Current Topics in Microbiology and Immunology. 1989; 140:19-31.
Sodetz JM and Plumb ME. Complement: Terminal Pathway. Encyclopedia of life
sciences. 2001; Nature Publishing Group: www.els.net.
Steckel EW, Welbaum BE, and Sodetz JM. Evidence of direct insertion of terminal
complement proteins into cell membrane bilayers during cytolysis: labeling by a
photosensitive membrane probe reveals a major role for the eighth and ninth components.

Journal of Biological Chemistry. 1983; 258:4318-4324.
Steckel EW, York RG, Monahan JB, and Sodetz JM. The eighth component of human
complement: purification and physico-chemical characterization of its unusual subunit

structure. Journal of Biological Chemistry. 1980; 255:11997-12005.
Sunyer JO, Tort L, and Lambris JD. Structural C3 diversity in fish: characterization of
five forms of C3 in the diploid fish Sparus aurata. Journal of Immunolology. 1997;

158:2813-21.

Sunyer JO, Zarkadis IK, and Lambris, JD. Complement diversity: a mechanism for

generating immune diversity? Immunology Today. 1998; 19:519-523.
Sunyer JO, Zarkadis IK, Sahu A, and Lambris JD. Multiple forms of complement C3 in
trout that differ in binding to complement activators. Proceedings of the National

Academy of Sciences. 1996; 93:8546-51.
Suzuki NM, Satoh N, and Nonaka M. C6-like and C3-like molecules from the
cephalochordate, amphioxus, suggest a cytolytic complementsystem in invertebrates.
Journal of Molecular Evolution. 2002; 54:671-679.
Swofford, DL. PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods).
Version 4. 2002. Sinauer Associates, Sunderland, Massachusetts.
Terado T, Nonaka MI, Nonaka M, and Kimura H. Conservation of the modular structure
of complement factor I through vertebrate evolution. Journal of Developmental and

Comparative Immunology. 2002; 26:403-13.
Terado T, Smith SL, Nakanishi T, Nonaka MI, Kimura H, Nonaka M.Occurrence of
structural specialization of the serine protease domain of complement factor B at the
emergence of jawed vertebrates and adaptive immunity. Immunogenetics. 2001;53:250-4.

61

Trojer P, Wojnar P, Merschak P, and Redl B. Complement component C8y is expressed

in human fetal and adult kidney independent of C8a. FEBS Letters. 1999; 446:243-6.
Thompson JD, Gibson Ti, Plewniak F, Jeanmougin F, and Higgins DG. The
CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment

aided by quality analysis tools. Nucleic Acids Research 1997; 25:4876-82.
Thomson JD, Higgins DG, and Gibson TJ. ClustalW: improving the sensitivity of
progressive multiple sequence alignment through sequence weighting, position-specific

gap penalties and weight matrix choice. Nucleic Acids Research. 1994; 22:4673-80.
Uemura T, Yano T, Shiraishi H, and Nakao M. Purification and characterization of the
eighth and ninth components of carp complement. Molecular Immunology. 1996; 33:

925-32
Volanakis J and Frank MM. Overview of the complement system. In: Volanakis, editor.
The human complement system in health and disease. New York: Marcel Dekker. 1998;

p. 9-31.
Wakoh T, Ikeda M, Uchino R, Azumi K, Nonaka M, Kohara Y, et al. Identification
of transcripts expressed preferentially in hemocytes of Ciona intestinalis that can be used

as molecular markers. DNA Research. 2004;11:345-52.
Wells L, Vosseller K, and Hart GW. Glycosylation Nucleocytoplasmic Proteins: Signal

Transduction and O-GlcNAc. Science. 2001; 291:2376-8.
Young JD, Cohn ZA, Podack ER. The ninth component of complement and the poreforming protein (perforin 1) from cytotoxic T cells: structural, immunological, and

functional similarities. Science. 1986; 233:184-90.
Young JD, Liu CC, Leong LG, and Cohn ZA. The pore-forming protein (perforin) of
cytolytic T lymphocytes is immunologically related to the components of membrane
attack complex of complement through cysteine-rich domains. Journal of Experimental
Medicine. 1986; 164:2077-82.

62

